
ğŸ†” **Meeting Identifier**  
**AO001AW1418976**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Adrian Pena** on **January 09, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **January 09, 2024 at 10:00 AM**, a significant meeting was led by **Adrian Pena**,  
serving as **Head of Department of Studies - Ms.**.  
ğŸ‘¤ **Meeting Leader**  
**Adrian Pena** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: A meeting is scheduled for January 9, 2024 from 10:00 to 11:00 hrs. via zoom, link to be sent on 01-08-2024.  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Maria Paz Martinez** â€“ Interest Manager, representing Arquimed Importer Ltda.
- **Sebastian Manzano** â€“ Lobbyist, representing Arquimed Importer Ltda.
- **Sergio Figueroa** â€“ Interest Manager, representing Arquimed Importer Ltda.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- To know the progress of investments in medical equipment so far this year and what the expectations are for the end of the year  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/581982/741721).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1434864**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Manuel Najera** on **January 04, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **January 04, 2024 at 03:00 PM**, a significant meeting was led by **Manuel Najera**,  
serving as **Head of Department of Ministerial Advisory**.  
ğŸ‘¤ **Meeting Leader**  
**Manuel Najera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: According to your request, you will be received by Dr. Manuel NÃ¡jera De Ferrari, Chief Advisor to the Cabinet of the Minister of Health Mac-Iver 541 3rd floor Contact 225740417  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Claudia Farjat** â€“ Interest Manager, representing nan
- **Jorge Romo** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Gene therapy for SMA  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/517173/675226).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1442206**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Albagli** on **January 03, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **January 03, 2024 at 12:00 PM**, a significant meeting was led by **Andrea Albagli**,  
serving as **Undersecretary of Public Health**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Albagli** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: According to your request, you will be received by the Undersecretary of Public Health, Mrs. Andrea Albagli Mac-Iver 541 3rd floor Contact 225740407  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jorge GOLDENBERG** â€“ Interest Manager, representing Extend
- **Barbara Orellana** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Discussing Sinovac's operation in Chile. Participating from the Ministry of Health are: Undersecretary of Health, Andrea Albagli I. Dr. MarÃ­a Paz Bertoglia. Dr. MarÃ­a Soledad MartÃ­nez. And from Sinovac Biotech, Barbara Orellana, Jorge Goldenberg, Min Liang. Topic: Sinovac's operation in Chile.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/557884/674329).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1453346**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **January 09, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **January 09, 2024 at 04:00 PM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: It will be sent via email link of teams  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Maria Guzman** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Members: - MarÃ­a JosÃ© GuzmÃ¡n- Omar Landaeta- Tamara DobertiThey present innovative therapies for AIJ and request their incorporation into the GES. It is reported that the basket process is already closed and that AIJ was not prioritized. They agree to send information regarding price, inclusion criteria and evidence.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/733167).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1454820**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **January 11, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **January 11, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Zoom will send a link to the email Link https://us02web.zoom.us/j/89404768636 Password 432946  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Vega** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of clinical data, value proposition and economics for the drugs Encorafenib for colon cancer and Encorafenib/binimetinib for melanoma. (THEY AGREED TO ASK FOR ANOTHER LOBBY)  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/675025).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1464692**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **January 17, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **January 17, 2024 at 02:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by the head of the Health Planning Division, Telephone: 225740458, the meeting will be held via telematics with the following connection link: https://us02web.zoom.us/j/83050884911?pwd=Q0FYRG9mclRQTXQ1b0E2QmZ0N3RkZz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Dinka Joyce Basic Eissler** â€“ Interest Manager, representing nan
- **Lorena Vega** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- An alternative to Somatropin will be presented for pediatric patients due to the global shortage of the active ingredient and the problems generated by this lack in the public system. *Presentation of Somatrogon, long-acting growth hormone. *Acceleration of health registration is requested due to the large supply of other growth hormones. *The audience is joined by: Macarena Lagos, Rut 13.026731-9, PFIZER Andrea Guerrero, GES-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/677060).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1465036**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **January 25, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **January 25, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom link will be sent by email REMEMBER THAT LOBBY LASTS HALF AN HOUR. Link https://us02web.zoom.us/j/84952162719 Password 038661  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ana Karachon** â€“ Interest Manager, representing Pfizer Chile S.A.
- **Lorena Vega** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Review of the scientific evaluation report of the evidence for the drug Tofacitinib in ulcerative colitis and Psoriatic Arthritis for the extension of the fourth decree of the Ricarte Soto Law 2023  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/684122).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1470623**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Letelier** on **January 12, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **January 12, 2024 at 08:30 AM**, a significant meeting was led by **Maria Letelier**,  
serving as **Head of Digital Health Department**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Letelier** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join Zoom Meeting https://us02web.zoom.us/j/86191889416?pwd=ZytqQmxRbWIyR1drYmFxR3JRbDJZdz09 Meeting ID: 861 9188 9416 Passcode: 020779  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Torrealba Diaz** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Janine Molina** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Rodrigo Campos** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- They are in the Angels strategy and the proposal to work with APS. They present gaps in APS for ERC dg. They present the work carried out with the community.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/305882/676712).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1483783**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **February 01, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **February 01, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: ZOOM WILL BE SENT TO THE EMAIL Link https://us02web.zoom.us/j/88084607265 Password 143891  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Sonia Torrealba** â€“ Interest Manager, representing Novartis Chile S.A.
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Status of national coverage processes: Ricarte Soto Law (V Decree), GES 2025 and DAC 2024.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/686245).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1485078**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **March 06, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 50 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 06, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera, Head of the Health Planning Division, phone number 225740458. Connection link: https://us02web.zoom.us/j/88241299802?pwd=OU5wMVBqYjY5ZzZya0xTRk9pL3lMdz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 50 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Rony Lenz** â€“ Interest Manager, representing Lenz Consultants
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Daniela Paredes** â€“ Interest Manager, representing KENDALL CHILE COMMERCIAL LTDA.
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Request meeting to present budget impact study (Cost savings) of Nivolumab in neoadjuvant lung cancer (Checkmate816 Study) for evaluation of incorporation into health guarantees. Nivolumab presents savings in the public system by intervening early and correcting the trajectory of the expense of the patient with lung cancer in Chile. We request that the Head of the Department of Coordination of Guarantees and Health Benefits, Head of ETESA, and Head of the Cancer Agency may participate in the meeting. Dr. Francisco Orlando Jorquera, Oncologist INT, would also participate in the meeting. Budget impact study on Nivolumab in lung cancer as a neoadjuvant. The following people will join the Hearing: - Priscila GonzÃ¡lez, DIPRECE-MINSAL - Joan Cornejo MuÃ±oz, GES-MINSAL - Ramiro CofrÃ© CofrÃ©, GES-MINSAL - Francisco Orlandi, Rut 6,658 911-0 National Thoracic Institute  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/687561).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 50 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1485833**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Carmen Maria Aravena Cerda** on **February 27, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **February 27, 2024 at 09:00 AM**, a significant meeting was led by **Carmen Maria Aravena Cerda**,  
serving as **Head of Primary Care Division-SRA**.  
ğŸ‘¤ **Meeting Leader**  
**Carmen Maria Aravena Cerda** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The application will be received by Dr. Marcela Rivera and Carolina Neira, head(s) of the non-communicable diseases department of DIPRECE through the following link: Enter Zoom Meeting https://us02web.zoom.us/j/88446243047?pwd=dnNJaXJ3RW9YVjBialp5bnU0VXZFUT09  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Rodrigo Tobar** â€“ Interest Manager, representing nan
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Maria Guzman** â€“ Interest Manager, representing nan
- **Dr. Marcela Rivera** â€“ nan, representing nan
- **Carolina Neira** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- meeting is requested to evaluate the proposal for advanced lipid management in the health system.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/628861/706338).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1491102**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Raquel Child Goldenberg** on **January 08, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **January 08, 2024 at 09:30 AM**, a significant meeting was led by **Raquel Child Goldenberg**,  
serving as **Head of the Office of Cooperation and International Affairs (OCAI).**.  
ğŸ‘¤ **Meeting Leader**  
**Raquel Child Goldenberg** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Ministry of Health, Monjitas 689, 6th floor  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Alvaro Melys** â€“ Interest Manager, representing nan
- **Jose Pozo** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Mariella Francesca Parodi Soza** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- HIV prioritization in the next EVC for GES 2025-2028  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/628244/676433).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1491651**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Bertoglia** on **January 11, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **January 11, 2024 at 09:30 AM**, a significant meeting was led by **Maria Bertoglia**,  
serving as **Head of Immunization Department - DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Bertoglia** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Video conference. Invitation will arrive to the email address provided.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Reinaldo Cornejo** â€“ Interest Manager, representing Tencofarma Pharmaceutical Industry
- **Moira Kalajzic** â€“ nan, representing nan
- **Leslie Uribe** â€“ nan, representing nan
- **Maria Bertoglia** â€“ nan, representing nan
- **Carolina De Pablo** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Development: The Immunization Department met with the supplier to coordinate the HPV vaccination strategy for 2024, reviewing the logistical and administrative particularities of said implementation.=====Request: Review the implementation plan for the acquisition of Gardasil for the National HPV Immunization Program.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/490837/675205).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1491798**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **February 29, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **February 29, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Zoom link was sent by email Meeting must last 30 minutes. Link https://us02web.zoom.us/j/85785134390 Password 175500  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nicolas AmenÃ¡bar** â€“ Interest Manager, representing Roche Chile Limited
- **Ximena Paredes** â€“ Interest Manager, representing nan
- **Fiorella Rehbein** â€“ Interest Manager, representing nan
- **Catherine Gejman** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of oncology products to incorporate solutions for cancer patients through DAC  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/686228).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1493637**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **February 29, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 22 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **February 29, 2024 at 04:03 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom will be sent by email Link https://us02web.zoom.us/j/85760042174 Password 214084  
- **Format**: Videoconference  
- **Duration**: 0 hours, 22 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **John Corona** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- In the context of the application of subcutaneous Natalizumab for the Multiple Sclerosis care protocol in Ley Soto, we respectfully request to meet with Andrea Guerrero and/or Joan Cornejo with the intention of following up and knowing the status of the process. Thank you!  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/686331).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 22 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1495718**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Carlos Pozo** on **January 22, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **January 22, 2024 at 09:00 AM**, a significant meeting was led by **Carlos Pozo**,  
serving as **Head (S) Investment Division**.  
ğŸ‘¤ **Meeting Leader**  
**Carlos Pozo** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Investment Division - Minsal Mac-Iver No. 541, 3rd Floor, Office 34.  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Luis Barrios** â€“ Interest Manager, representing nan
- **Pablo Pizarro** â€“ Interest Manager, representing CARE Foundation
- **Adrian Pena** â€“ nan, representing nan
- **Ignacio Morales** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Design and construction of a Comprehensive Oncology Center in the municipality of Cerrillos in coordination with the Ministry of Health.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/618103/678735).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1497591**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **February 14, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **February 14, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: They will be received electronically by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, with the following connection link: https://us02web.zoom.us/j/84941293813?pwd=Q3ZIL2VkR1ZDQkxkSFVXNzZULzdnZz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Angelica Kart** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Leticia Murray** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Nicolas Deantoni** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Cecilia Barria** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Align the requirements of the Ministry of Health for the implementation of the immunization campaign for RSV 2024.*Check for the pending response from the Minister regarding the purchase of Palivizumab. It is explained that this year Nirsevimab was acquired for all patients, so Palivizumab will not be acquired.*The following person joins the Hearing:- Candelaria Alonso, DNI 27954049_Astrazeneca- Ramiro CofrÃ©_GES-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/687552).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1498135**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **February 14, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **February 14, 2024 at 03:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, with the following connection link: https://us02web.zoom.us/j/85279737525?pwd=ZDFwdldSSXRsY0tSUDZZMG55L2xvQT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of updated clinical data on Nivolumab (OPDIVO) in 1L gastric cancer. (Checkmate 649)ETESA and the Department of Health are requested to participate*Presentation of Nivolumab for gastric and esophageal cancer.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/687554).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1499153**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **March 07, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 07, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom link will be sent by email Link https://us02web.zoom.us/j/85353581826 Password 786413  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Tristan Carvajal** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- The lack of resources and access to innovative therapies is one of the major limitations at the public level for the treatment of cancer. The incorporation of LENVATINIB in the GES basket represented a quantum leap for the treatment of REFRACTORY THYROID CANCER since patients only had access to a drug through DAC that was much inferior in potency and safety. In addition, the laboratory presented an economic proposal where the innovative drug (lenvatinib) was cheaper than sorafenib. There is a second indication (HEPATOCARCINOMA) where the proposal was presented, but ETESA only considered Global Survival and the total number of Adverse Effects as parameters. The REFLECT study (Head to Head lenvatinib vs sorafenib) showed that the response rate of LENVATINIB was 24% vs 9% of sorafenib (the approved first-line immunotherapy Atezolizumab/Avastin has a response rate of 29%). Furthermore, the most relevant adverse effect of LENVATINIB is Hypertension and not the complicated hand/foot syndrome... metrics that were not considered, although the Overall Survival in this study was not statistically significant (it was a non-inferiority study) the median OS of LENVATINIB is greater than that of sorafenib. As additional data, the cost of treatment at therapeutic doses (12 mg Lenvatinib and 800 mg sorafenib) is cheaper with LENVATINIB, we estimate that the savings for the MINSAL only by replacing the drug financed by DAC (sorafenib) would reach about 200 million per year.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/687898).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1501317**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Bertoglia** on **January 29, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **January 29, 2024 at 04:00 PM**, a significant meeting was led by **Maria Bertoglia**,  
serving as **Head of Immunization Department - DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Bertoglia** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: A summons will be sent to your email.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Hugo Dibarboure** â€“ Interest Manager, representing Sanofi Pasteur S.A.
- **Carlos Porley** â€“ nan, representing nan
- **Paula Mesyngier** â€“ nan, representing nan
- **Florence Esquivel** â€“ nan, representing nan
- **Maria Bertoglia** â€“ nan, representing nan
- **Tamara Astudillo Concha** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Hearing development: A discussion is held on immunization strategies against respiratory syncytial virus, specifically on epidemiological and logistical aspects. A proposal is received for dissemination and communication support for the strategies, and institutional considerations are shared.=================Hearing request: A virtual meeting is requested for next week for a presentation by the Sanofi Vaccines Southern Cone Medical and Public Affairs Team, and also to report on available support for the implementation of Nirsevimab in the 2024 Immunization Campaign.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/490837/679651).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1503080**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **February 21, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **February 21, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, Telephone: 225740458. Connection link: https://us02web.zoom.us/j/89604874454?pwd=aU9OdmJwOVdURDIrWHd0VXU1TDMyUT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Heise** â€“ Interest Manager, representing nan
- **Maria Verdugo** â€“ Interest Manager, representing nan
- **Kenny Arciniegas** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- At the request of the Department of Comprehensive Management of Cancer and Other Tumors, a meeting is requested to present to ETESA and the GES and LRS Technical Secretariat a new health technology for the treatment of Relapsed/Refractory Acute Myeloid Leukemia FLT3+, which was approved by the ISP last October. * Gilteritinib, a drug for the treatment of AML, is presented.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/687556).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1503103**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **March 14, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 14, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom will send link Link https://us02web.zoom.us/j/85984407081 Password 799932  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Juan Sebastian Robledo Arango** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Nicolas Sandoval** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- In line with the recommendation of the new clinical guidelines and in view of the update of the GES 2025, a hearing is requested to present the new real-life evidence, indication and proposal for the incorporation of triple closed therapy ICS/LABA/LAMA (Fluticasone furoate/vilanterol/umeclidinium) approved for asthma.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/689635).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1503506**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Yasmina Viera** on **March 06, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **March 06, 2024 at 09:30 AM**, a significant meeting was led by **Yasmina Viera**,  
serving as **Head of Legal Division**.  
ğŸ‘¤ **Meeting Leader**  
**Yasmina Viera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Connection link will be sent in a timely manner  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Claudia Farjat** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Spinal Muscular Atrophy, review of the gene therapy billing process and contract bases.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/458394/727246).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1503869**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **March 21, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 45 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 21, 2024 at 03:15 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom link will be sent to the email Link https://us02web.zoom.us/j/85000090119 Password 205910  
- **Format**: Videoconference  
- **Duration**: 0 hours, 45 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Oriana Alderete** â€“ Interest Manager, representing Tencofarma Pharmaceutical Industry
- **Enrique Salinas** â€“ Interest Manager, representing Tencofarma Pharmaceutical Industry
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Review of value proposition for DAC process of blinatumomab product for acute lymphoblastic leukemia  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/691462).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 45 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1506061**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **February 21, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **February 21, 2024 at 03:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/87116379757?pwd=NUNGZnB6OVBBelBhbjRmOTBpMEs3dz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ximena Paredes** â€“ Interest Manager, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of Roche's oncology portfolio*Drugs that can reduce the cost of DAC are presented.*The following people join the Audience:- NicolÃ¡s AmenÃ¡bar, Rut 16013638-3-Roche- Fiorella Santos, Rut 26822901-9-Roche- Catherine Gejman, Rut 17982869-3  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/687558).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1507322**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **March 06, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 55 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 06, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/83687198023?pwd=Rk8ycVg3dXFJTzRHNjZkeEJBUDJiZz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 55 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the proposed value for Nivolumab Kidney Cancer 1L CM 214. It is requested that ETESA, Health Guarantees and the Cancer Department may also participate. *Presentation of a drug for Kidney Cancer, the stage at which it is deprioritized in the evaluation to make an offer is consulted. *The following people join the Hearing: - Francisca Plaza, DIPRECE-MINSAL - Paula Nahuelhual, ETESA-MINSAL - Andrea Guerrero, GES-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/687560).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 55 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1508503**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **April 04, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 04, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Meeting Join via your computer, mobile app, or room device Meeting ID: 253 132 630 07 Passcode: JA5ykq  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ximena Paredes** â€“ Interest Manager, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up to the ARC Evrysdi proposal  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/697425).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1509525**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Hoffmann** on **May 07, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 3 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 07, 2024 at 03:21 PM**, a significant meeting was led by **Maria Hoffmann**,  
serving as **Head of the Training, Capacity Building and Continuing Education Department**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Hoffmann** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Minsal is inviting you to a scheduled Zoom meeting. Subject: Meeting Lobby AO001AW 1509525 Boehringer Ingelheim Ltda Time: May 7, 2024 03:00 PM Santiago Join Zoom Meeting https://us02web.zoom.us/j/89177506802?pwd=U3VGNHUwNStZdUpyelJOR0JWUWQ3dz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 3 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Rodrigo Campos** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Light Maria Alvarez** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Introducing the Angles initiative, an international, non-profit, non-promotional collaborative project. It is run in collaboration with the World Stroke Organization (WSO), the European Stroke Organization (ESO) and regional and national organizations, stroke societies in more than 50 countries. Continuing education courses in stroke for clinical and non-clinical personnel who have contact with this type of emergency.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/471785/709898).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 3 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1514493**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Bertoglia** on **March 08, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 08, 2024 at 12:00 PM**, a significant meeting was led by **Maria Bertoglia**,  
serving as **Head of Immunization Department - DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Bertoglia** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be contacted by the Head of the PNI DIPRECE. Telephone: 225688128  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ana Karachon** â€“ Interest Manager, representing Pfizer Chile S.A.
- **Chris Ariyan** â€“ Interest Manager, representing Pfizer Chile S.A.
- **Sol GoÃ±i** â€“ Interest Manager, representing nan
- **Norka Napuri** â€“ Interest Manager, representing nan
- **Maria Bertoglia** â€“ nan, representing nan
- **Sara Correa** â€“ nan, representing nan
- **Valentina Pino** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Development of Hearing:1) Respiratory Syncytial Virus Vaccineâ€¢ Representatives of the supplier appreciate the information received regarding the request for prioritization of record review reported to the ISP by the PNI.â€¢ This does not involve a decision to incorporate any of the available vaccines into the vaccination program by the Ministry of Health.2) New vaccine for pneumococci (PCV20)â€¢ Information is shared on the new Pfizer vaccine for the prevention of pneumocco infections, which has prevention for 7 additional serotypes compared to the one currently supplied by the company to the PNI in Chile (PCV13).â€¢ This vaccine already has health authorization from the reference agencies and will be submitted for registration in Chile in the following days.â€¢ Regarding the request to be able to present the scientific evidence of this vaccine to the Ministry of Health, the supplier will share with the PNI the available background information, and will coordinate a technical meeting so that the company's medical area can present the information in more detail and resolve doubts.3) Strategies for the prevention of Covidâ€¢ The close collaboration sustained to make It is possible that Chile was the first country in Latin America to have the most up-to-date Covid vaccine to date.â€¢ Regarding the oral antiviral for the management of Covid infections (Paxlovid), the supplier appreciates the guidelines received regarding requesting a meeting with the Diprece and Diplas Depts., who are the areas that are handling the decisions regarding the continuity of supply and review of evidence.4) Support for educational campaigns within the framework of the Minsal winter campaignâ€¢ Information is shared on the priority communication areas that the Ministry is addressingâ€¢ The full independence of the communication campaigns led by the Minsal is reaffirmed.â€¢ In accordance with the guidelines received, suppliers will contact the Dept. Ministry of Communications.============Request for Hearing: To address with the Undersecretary of Public Health, collaborative initiatives in which our company can support prevention strategies, for respiratory infections and management of chronic diseases, within the framework of the winter campaign led by the Ministry of Health  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/490837/696636).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1514973**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **March 20, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 20 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 20, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera, Head of the Health Planning Division. Telephone 25740458 With the following connection link: https://us02web.zoom.us/j/87522833341?pwd=bWN0eFR6V3k1cUFtRGIyUTRqbGVXQT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 20 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Maria Pons** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Status of the DAC/LRS process and next steps.*Joan Cornejo MuÃ±oz, GES-MINSAL, joins the Hearing.*He needs to know the progress of the LRS and DAC decrees.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/691946).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 20 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1514981**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **March 27, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **March 27, 2024 at 03:30 AM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: https://us02web.zoom.us/j/82655494084 Password 351338  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Andrea Gomez** â€“ Interest Manager, representing Abbvie Pharmaceuticals Limited
- **Maria Pons** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Pamela LlantÃ©n 16,558,481-3, Macarena Moya 16,470,254-7 and Sung Kim 14,694,629-1 from the Ministry of Health attend. Andrea GÃ³mez 13,464,314-5 (Abbvie medical advisor) and Alejandra Pons 13,548,316-8 (Abbvie access manager) attend. Alejandra Pons and Andrea GÃ³mez present venetoclax, an oral medication for the treatment of leukemias (CLL and AML) selective inhibitor of BCL-2. They are suggested to inform the DAC team.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/693330).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1519261**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Albagli** on **March 22, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **March 22, 2024 at 09:00 AM**, a significant meeting was led by **Andrea Albagli**,  
serving as **Undersecretary of Public Health**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Albagli** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: According to the request, the Undersecretary of Public Health, Ms. Andrea Albagli Iruretagoyena, and part of her team will contact you. Contact 225740407  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Barbara Orellana** â€“ Interest Manager, representing nan
- **Run Chen** â€“ Interest Manager, representing nan
- **Weining Meng** â€“ Interest Manager, representing nan
- **Zijian Tang** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Discuss with the Ministry of Health about the R&D project for Sinovac vaccine development.Between March 9 and 13, 2024, due to a visit by the general manager to Chile.03-22-2024In addition, Jorge Goldenberg and Eugan Song will participate on behalf of SINOVAC.On behalf of the Minsal, the Undersecretary of Public Health, Andrea Albagli, MarÃ­a Paz Bertoglia, and Cecilia Morales.Topic: General project on vaccine development.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/557884/692296).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1520180**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **April 23, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 23, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join the meeting now Meeting ID: 267 889 041 063 Passcode: FT6zMU  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Maria Guzman** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- brief meeting is requested with Joan Cornejo (Ricarte Soto Law Coordination Office) to discuss the following topics: - Patient approval commissions for the different pathologies - Schedule for the extraordinary decree December 2024 (mentioned in the LRS Surveillance and Control Commission) Thank you very much  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/700807).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1522214**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Edith Carmen Ortiz NuÃ±ez** on **March 25, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 25, 2024 at 03:00 PM**, a significant meeting was led by **Edith Carmen Ortiz NuÃ±ez**,  
serving as **Head (S) Department of the National Program for the Prevention and Control of HIV/AIDS and STIs DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Edith Carmen Ortiz NuÃ±ez** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Application for in-person hearing is accepted, which will take place on Monday, March 25 at 3:00 p.m., at Monjitas 565, 7th floor, Office 716, DIPRECE, Department of National Program for the Prevention and Control of HIV/AIDS and STIs. Participants: Dr. Leonard  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jose Pozo** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Mariella Francesca Parodi Soza** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- APPLICATION FOLIO NUMBER AO001AW 1522214Glaxo Smith Kline Farmaceutica LTDA.DATE 03/25/2024In person START TIME 3:00 PM END TIME3:45 PM DOCUMENT DELIVERY NOSEEING SUBJECTS ACCORDING TO REQUEST Meeting with the purpose of addressing two topics, Pediatric Dolutegravir and consultations on progress/definitions for the next EVC evaluation for the GES HIV pathology decree.ATTENDANTS NAME RUT QUALITY ATTENDS YES NO JosÃ© Pozo 17,511,507-2 Interest Manager X Mariella Francesca Parodi Soza 12,638,682-6 Interest Manager X MEETING NOTES TOPIC ADDRESSED In relation to the meeting subjects: 1.- Dolutegravir Pediatric: they were aware of the donation received from PAHO and with an expiration date of May 2024. They indicate that they have the product available in the country in case a new purchase is put out to tender. It is reported that with the donation from PAHO we have covered the entire year 2024, the delivery of the import was made in 2 distributions considering the validity of the product. The second delivery with greater validity is in process. It is reiterated that the management of the purchase of ARVs is in charge of DIGERA and CENABAST. 2.- Advances/definitions for the next EVC evaluation for updating Decree 2025-2028: they consult on news or changes in the consideration of HIV in the update of Decree 2025-2028. It is reported that there are no changes to what was reported through minutes No. 130 of the GES Advisory Council. They also consult about the EVC of the update of the Decree and it is indicated that the queries must be made to the Technical Secretariat GES.ACCOMPANYING AUTHORITY YES X NOEntity NameDR. LEONARDO CHANQUEO DEPT. VIHSIDAITS / MINSALMARÃA TERESA SILVA QUILODRÃN DEPT. VIHSIDAITS / MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/275447/693877).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1522638**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **April 25, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 25, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Meeting Join via your computer, mobile app, or room device Click here to join the meeting Meeting ID: 275 292 038 629 Passcode: qicSCV Download Teams | Join on the web Learn more | Option  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Cristobal Bravo Fuenzalida** â€“ Interest Manager, representing Roche Chile Limited
- **Daniela Munoz** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Dear Sirs, we are requesting a meeting to request information on the evaluation of DAC proposals. Additionally, please provide information on the products that will remain under Sandoz Chile after the official division with the Novartis laboratory, so that we can coordinate our products in case they are approved in the form sent.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/701587).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1522758**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **May 02, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 20 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 02, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent by mail to Sonia Torrealba  
- **Format**: Videoconference  
- **Duration**: 0 hours, 20 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Sonia Torrealba** â€“ Interest Manager, representing Novartis Chile S.A.
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Update on GES coverage process, Ricarte Soto Law and DAC.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/703979).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 20 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1522917**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **March 19, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 19, 2024 at 02:00 PM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Meeting Join via your computer, mobile app, or room device Click here to join the meeting Meeting ID: 278 982 916 872 Passcode: un8Y5o Download Teams | Join on the web  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Alejandra Cisneros** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Nicolas Deantoni** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Guests:- Alejandra Cisneros- Macarena Moya- Christian Morales- Pamela Llanten- Vijayran- Tamara DobertiThey presented the two molecules ravulizumab and eculizumab for paroxysmal nocturnal hemoglobinuria, they reported that eculizumab is being taken off the market and they request that patients who are currently using it switch to ravulizumab. Tamara agrees to hold an intra-ministerial meeting to analyze the information given that the cases that are currently with eculizumab are patients under judicial review. If in two months we have not contacted the laboratory, they must request a lobby. They agree to send the presentation, economic offer and any other information regarding the change of molecule. Tamara Doberti Herrera  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/706972).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1524854**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Bertoglia** on **March 14, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 14, 2024 at 03:00 PM**, a significant meeting was led by **Maria Bertoglia**,  
serving as **Head of Immunization Department - DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Bertoglia** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: They will be contacted by the PNI-DIPRECE Department Telephone: 225688128  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Marjorie Vasquez** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Jessica RUT Jassir Felfle** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Maria Bertoglia** â€“ nan, representing nan
- **Leslie Soto** â€“ nan, representing nan
- **Siusee Lee** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Hearing development:The evidence related to the impact on public health of RSV outbreaks during the 2023 winter season and its impact on the healthcare network is presented at the hearing.Provider representatives present the results of a disease burden model based on the local epidemiological context of RSV.The PNI requests that they share the presentations and documents that support this evidence, to be evaluated by the technical team.======Hearing request:Requests an audience to present the update on the ongoing clinical development of the GSK vaccine against RSV and to address the Ministry's requirements regarding protection strategies against this disease in the population over 60 years of age for the 2024 winter season.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/490837/696643).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1525012**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **March 27, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 27, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: They will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458. Please send the presentation to the following email: yasna.aguilera@minsal.cl Connection link: https://us02web.zoom.us/j/81135147715?pwd  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the proposed value of Nivolumab in 1L Lung cancer CM 9LA. It is requested that ETESA, Health Guarantees and the Cancer Department may also participate. * A meeting is held for lung and bladder cancer. * The following people join the Hearing: - Miguel Paredes, CANCER DEPT.-MINAL - Andrea Guerreo, GES-MINSAL - Nancy Osses, Rut 12.849.967-9, Bristol Myers Squibb  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/693872).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1525041**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **March 27, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 27, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: They will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458. Please send the presentation to the following email: yasna.aguilera@minsal.cl Connection link: https://us02web.zoom.us/j/89579748170?pwd  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the proposed value of Nivolumab in adjuvant bladder cancer. It is requested that ETESA, Health Guarantees and the Cancer Department may also participate. * The same zoom link is used as the previous lobby (AO001AW1525012) * The following people join the audience: -Andrea Guerrero, GES-MINSAL-Victoria Hurtado, ETESA-MINSAL-Francisca Plaza, CANCER DEPT.-MINSAL-Nancy Osses, Rut 849.967-9, Bristol Myers Squibb  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/693881).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1525686**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Ivan Paul** on **March 12, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **March 12, 2024 at 10:00 AM**, a significant meeting was led by **Ivan Paul**,  
serving as **Head of the Healthcare Network Management Division**.  
ğŸ‘¤ **Meeting Leader**  
**Ivan Paul** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Paulina Torrealba and Karina Trujillo, professionals from the Healthcare Network Management Division who handle these issues. Their contact information is 225740560 Monica Saldias  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Rodrigo Enriquez** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Alvaro Sepulveda** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Natalia Gandolfi** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- An audience is requested with the head of the GES and integrated networks department of the Healthcare Network Management Division (DIGERA), to present new information on the treatment of cardio-renal-metabolic pathologies with iSGLT2 and to consult on the management's challenges regarding the prevention and management of type II Diabetes, Chronic Kidney Disease (CKD) and Heart Failure (HF).  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/606206/697279).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1525763**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Letelier** on **April 26, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **April 26, 2024 at 08:00 AM**, a significant meeting was led by **Maria Letelier**,  
serving as **Head of Digital Health Department**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Letelier** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join Zoom Meeting https://us02web.zoom.us/j/84309139014?pwd=ZTR2MUpzNGNQVEZuRTBwbWZqb3J2QT09 Meeting ID: 843 0913 9014 Passcode: 794226  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Rodrigo Enriquez** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Alvaro Sepulveda** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Natalia Gandolfi** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- An audience is requested with the head of the Digital Health Department to present new information on the treatment of cardio-renal-metabolic pathologies with iSGLT2 and its relationship with primary health care strategies through the Digital Hospital. Also, to consult on the challenges of the Directorate regarding the prevention and management of type II Diabetes, Chronic Kidney Disease (CKD) and Heart Failure (HF).  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/305882/704151).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1526981**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Ximena Aguilera** on **March 05, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **March 05, 2024 at 09:00 AM**, a significant meeting was led by **Ximena Aguilera**,  
serving as **Minister(ess)**.  
ğŸ‘¤ **Meeting Leader**  
**Ximena Aguilera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Mac-Iver 541 floor 3 Contact 225740412-13  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Alejandra Cisneros** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Leticia Murray** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Nicolas Deantoni** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Nicolas Castiglioni** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Exploring opportunities for collaboration in respiratory virus innovation.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/508615/687096).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1529607**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **April 30, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **April 30, 2024 at 10:30 AM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Attendees: - Hugo Ossandon - Felipe Vera - JoaquÃ­n Pedre - Juan Corona - Macarena Moya - Pamela Llanten - Tamara Doberti Biogen requests information on how to move forward in risk-sharing agreements. They had a previous Lobby with the head of DIPLAS where they have  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **John Corona** â€“ Interest Manager, representing nan
- **Joaquin Pedre** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- In the framework of the efforts to find a solution to the issue of Spinal Muscular Atrophy, we respectfully request a meeting with NUT, Tamara Doberti, in order to share and make available to the Life Cycle Area Working Team (and whoever else may consider it relevant) the background, perspective, international experience and the most recent scientific information available on the disease and its treatment.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/706846).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1530575**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **April 17, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 32 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 17, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom  
- **Format**: Videoconference  
- **Duration**: 0 hours, 32 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Also attending are Nancy Osses from Bristol Myers Laboratory, Rut: 12,849,967-9 and Carolina ZÃ¡rate Garrido, Department of Comprehensive Management of Cancer and Other Tumors. Rut: 15,839,195-3. Meeting starts at 3:00 p.m. Bristol Myers Laboratory (LBM) presents results of the PHASE III CM649 study nivolumab + chemotherapy for the treatment of gastric cancer, gastroesophageal junction cancer, and esophageal or advanced adenocarcinoma. The presentation ends and the Cancer Department is asked if the incorporation of new treatments is being considered. The Cancer Department responds that what can be reported about gastric cancer is that the clinical practice guide for gastric cancer is currently in the process of being developed and that it could be completed at the end of this year or early 2025. LBM consults with those who can turn to the MINSAL to evaluate this new therapy. The Cancer Department indicates that they could request the GES Department. They ask what criteria are used to prioritize cancers. The Cancer Department reports that one of the criteria stipulated by law is national epidemiology. They ask if MINSAL intends to provide resources to support local initiatives that allow obtaining clinical information on the use of certain therapies. The Cancer Department indicates that this information is not available. LBM indicates that they do not know if it is in the interest of MINSAL to evaluate these new therapies, but they declare that they are willing to discuss the costs that these therapies imply, specifically for the group of patients that would benefit. The meeting ends at 3:32 p.m.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/699758).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 32 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1531480**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Jose Arce Castillo** on **March 21, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **March 21, 2024 at 10:00 AM**, a significant meeting was led by **Maria Jose Arce Castillo**,  
serving as **Head of Department of Food and Nutrition - DIPOL SSP**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Jose Arce Castillo** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Meeting Join via your computer, mobile app, or room device Click here to join the meeting Meeting ID: 239 785 831 93 Passcode: RNdnbh Download Teams | Join on the web Learn more | Options  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jose Allemant** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Addressing the impact on labeling of Abbott nutritional formulas.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/295080/700157).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1531799**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Christian Garcia** on **March 22, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **March 22, 2024 at 11:00 AM**, a significant meeting was led by **Christian Garcia**,  
serving as **Head of Epidemiology Department**.  
ğŸ‘¤ **Meeting Leader**  
**Christian Garcia** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be contacted by the Epidemiology Department. Telephone: 225740122 or 225740123  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jose Allemant** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Addressing the sensitivity required for COVID testing  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/458386/691790).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1533546**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **May 08, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 08, 2024 at 03:35 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/84371851135?pwd=bUcxWFc3MHBmVkwzcFUvdXBnN2xvZz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Hans Kohler** â€“ Interest Manager, representing Roche Chile Limited
- **Patricio Jaureguiberry** â€“ Interest Manager, representing Science SPA
- **Aurea Duran** â€“ Interest Manager, representing nan
- **Augusto Penayo** â€“ Interest Manager, representing nan
- **Monica Mora** â€“ Interest Manager, representing nan
- **Cristina Martin-Rinconada** â€“ Interest Manager, representing nan
- **Valentina Marin Vargas** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Cystic Fibrosis in Chile and Presentation of the TRIKAFTA Value Story*Topics discussed: The procedures for incorporating Trikafta into collateral in Chile are being consulted.*The following people did not attend the hearing:-Hans Kohler, Scienza Chile SpA-Aurea Duran, Vertex Pharmaceuticals Inc.-Valentina Marin Vargas, ertex Pharmaceuticals Inc*The following people joined the hearing:-Eliana Ribeiro, Scienza Chile-Andrea Guerrero Ahumada, GES-MINSAL-Catherine De la Puente Agurto, ETESA-DIPLAS  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/705920).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1534239**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **May 02, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 45 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 02, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 45 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Rachel Marina Hernandez** â€“ Interest Manager, representing nan
- **Lorena Vega** â€“ Interest Manager, representing nan
- **Josefa Martinez Marinello** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the experience of implementing shared risk of the drug: Inotuzumab Ozogamicin in Chile.THE PRESENTATIONS ARE YET TO BE SENT  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/704070).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 45 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1535813**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Edith Carmen Ortiz NuÃ±ez** on **April 03, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 03, 2024 at 03:30 PM**, a significant meeting was led by **Edith Carmen Ortiz NuÃ±ez**,  
serving as **Head (S) Department of the National Program for the Prevention and Control of HIV/AIDS and STIs DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Edith Carmen Ortiz NuÃ±ez** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Dear Mr. Claudio Arredondo, Along with greetings, I am writing to inform you that audience AO001AW1535813 has been accepted by the head of the National Program Department for the Prevention and Control of HIV/AIDS and STIs, Dr. Leonardo Chanqueo Cornejo.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudio Arredondo** â€“ Interest Manager, representing Vitroscience Spa marketing and distribution company.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- To present information on the Oraquick Oral Fluid HIV Self-Test clinical device. The conversation will focus on our device and the media plan to be implemented soon, for the promotion, dissemination and placement throughout Chile and that we believe it is necessary for the Ministry to be aware of this matter, due to the notoriety and public interest that it will produce. The meeting is held telematically, via the zoom platform, with the applicant, Dr. Leonardo Chanqueo, Head of the National HIV / AIDS and STI Program of the Ministry of Health and Mayra Torres, Professional of said Program. Mr. Arredondo explains that the objective of this meeting is to present to the Ministry of Health, through the National HIV Prevention and Control Program, the Oral Fluid Self-Test device and the media plan to be implemented soon, for its promotion, dissemination and availability in Chile.Mr. Arredondo makes a presentation supported by a Power Point presentation and a promotional video, which, due to technological problems, cannot be heard. He reports that the Oral Quick device is already on sale in Salcobran pharmacies and that it will soon be available in chain and independent pharmacies. The HIV/AIDS and STI Program thanks the presentation.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/275447/695908).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1536461**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Patricia Contreras Cerda** on **March 20, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 40 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **March 20, 2024 at 03:00 PM**, a significant meeting was led by **Patricia Contreras Cerda**,  
serving as **Head of Department of Communicable Diseases - DIPRECE SSP**.  
ğŸ‘¤ **Meeting Leader**  
**Patricia Contreras Cerda** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Videoconference, this lobby hearing has been entrusted to EU Patricia Contreras - Head of the Department of Communicable Diseases, the link will be sent to you in due time, for any questions at 225749503,  
- **Format**: Videoconference  
- **Duration**: 0 hours, 40 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ana Karachon** â€“ Interest Manager, representing Pfizer Chile S.A.
- **Lorena Vega** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- We would be grateful if you could grant us a meeting with the Head of Diprece and the Diplas Department in order to discuss matters related to our company's oral antiviral Paxlovid, which is being used by the public and private networks in accordance with the guidelines of the Ministry of Health. This meeting is relevant for the purposes of product availability and updating of relevant information. The meeting is requested in accordance with the indication we received at the lobby meeting A0001AW1514493 (held on March 8 with areas of the Undersecretary of Public Health) where we were told that the matter should be reviewed with the Diprece and Diplas departments. The following participated in this hearing: Ms. Patricia Contreras (Head of the Department of Communicable Diseases/DIPRECE), Marisol ClaverÃ­a (DIPRECE), and on behalf of Pfizer, Ana Karachon, Lorena Vega, Natalia Serrano and Norka Napuri.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/174504/690992).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 40 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1537668**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **April 24, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 24, 2024 at 03:30 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Link https://us02web.zoom.us/j/82655494084 Password 351338  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Javier Tapia** â€“ Interest Manager, representing Arquimed Importer Ltda.
- **Tatiana Diannela Kraiser Miranda** â€“ Interest Manager, representing Arquimed Importer Ltda.
- **Felipe Turra** â€“ Interest Manager, representing nan
- **Peter Serafini** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- We request an audience to discuss how to increase access to genomic or genetic testing to enable precision or personalized medicine in the oncology area. This technology has a direct impact on the selection of cancer treatments and the determination of risk factors or predisposition to cancer, among others. We will bring experience from other countries in the region as well as tools on how to implement tests in the public health field, bringing benefits to patients in a cost-effective manner for the public health system. Attendees: Peter Serafini: RUT 546235151 (USA) - Illumina Tatiana Kraiser: RUT 15.960.937-5 - Arquimed They give a presentation in which they highlight the relevance of gene sequencing and how much the cost has dropped in 20 years. They highlight the hospitals that have implemented sequencing techniques. The problem is emphasized that there is no FONASA coding for these techniques, and that currently, there are establishments that are migrating from qPCR to sequencing, so these patients must pay for these tests at their own cost.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/701286).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1539422**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Ivan Paul** on **April 02, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 02, 2024 at 12:00 PM**, a significant meeting was led by **Ivan Paul**,  
serving as **Head of the Healthcare Network Management Division**.  
ğŸ‘¤ **Meeting Leader**  
**Ivan Paul** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Alejandra Cisneros** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- I request a meeting with you in order to understand and collaborate in the management derived from processes that impact healthcare networks due to the administration of high-cost drugs for ultra-rare diseases in the public network.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/606206/697284).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1544431**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Albagli** on **June 13, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 13, 2024 at 05:30 PM**, a significant meeting was led by **Andrea Albagli**,  
serving as **Undersecretary of Public Health**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Albagli** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: According to your request, you will be received by the Undersecretary of Public Health, Andrea Albagli Iruretagoyena. Mac-Iver 541 floor 3 Contact 225740407  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Julian Jerez** â€“ Interest Manager, representing Sanofi Pasteur S.A.
- **Sergio Montero** â€“ nan, representing nan
- **Hugo Dibarboure** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- face-to-face hearing is requested to review the progress of the 2024 Nirsevimab Campaign. The meeting would be attended by representatives of the Southern Cone (General Manager and Public Affairs Manager), who will visit Chile between April 11 and 12, 2024. Also as a local representative JuliÃ¡n Jerez (Country Manager of Sanofi Pasteur for Chile). Julian Perez and Sergio Montero from the Sanofi Laboratory attend. Topic: The objective of the meeting was to discuss the implementation of the Nirsevimab strategy. The company presents its planning for the coming years and sets out the conditions for possible future purchases by the Ministry  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/557884/716216).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1545077**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Susana Fuentealba** on **June 13, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 13, 2024 at 03:00 PM**, a significant meeting was led by **Susana Fuentealba**,  
serving as **Head of the Department of Clinical Processes and Hospital Management-SRA.**.  
ğŸ‘¤ **Meeting Leader**  
**Susana Fuentealba** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Vega** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of Somatrogon for LONG-TERM TREATMENT OF PEDIATRIC PATIENTS WITH GROWTH DISORDERS DUE TO INSUFFICIENT SECRETION OF GROWTH HORMONE (GH), for the ministerial Growth Hormone program.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/666957/747073).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1545331**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Adrian Pena** on **April 11, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 11, 2024 at 12:00 PM**, a significant meeting was led by **Adrian Pena**,  
serving as **Head of Department of Studies - Ms.**.  
ğŸ‘¤ **Meeting Leader**  
**Adrian Pena** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The following room is created: Link https://us02web.zoom.us/j/87417498305 Password 947976 With the Host Role you can apply security, record, activate the waiting room, close the microphones and manage the meeting. Password to claim the host role 4  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Marcelo Weisselberger** â€“ Interest Manager, representing Arquimed Importer Ltda.
- **Sebastian Manzano** â€“ Lobbyist, representing Arquimed Importer Ltda.
- **Jaime Oliva** â€“ Interest Manager, representing Mindray Medical Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Hold a meeting with the equipment investment team, learn about the 2024 investment panorama, announce the changes that Arquimed and Mindray have made and where we are aiming. Additionally, Mr. Roger Jia, Global Manager of Mindray and Marcelo Weisselberger, General Manager of Arquimed, will participate.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/581982/741728).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1545717**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Letelier** on **April 12, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **April 12, 2024 at 08:00 AM**, a significant meeting was led by **Maria Letelier**,  
serving as **Head of Digital Health Department**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Letelier** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join Zoom Meeting https://us02web.zoom.us/j/82442719819?pwd=bVBDbmNqamtubVN5cnlocmozaDltZz09 Meeting ID: 824 4271 9819 Passcode: 944761  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Barbara McDonald** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Juan Sebastian Robledo Arango** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- An audience is requested to learn about the projects and lines of work that Digital Health has in the short, medium and long term, in addition to learning about the process of creating a new cell focused on respiratory diseases.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/305882/698283).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1545719**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **May 15, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 15, 2024 at 03:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division and Head of ETESA, with the following connection link: https://us02web.zoom.us/j/83005655466?pwd=SUE3N2NvVUdhdHF1cWFCYlhnT1Vpdz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Guillermo Hernandez** â€“ Interest Manager, representing Abbvie Pharmaceuticals Limited
- **Paola Troncoso** â€“ Interest Manager, representing nan
- **Andres Aguilera** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of Deucravacitinib for the treatment of Psoriasis.*Topics Covered:-Presentation of a drug for psoriasis.*Paola Troncoso, BRISTOL MYERS SQUIBB CHILE, did not attend the hearing.*Anna Hevia, Rut 26.24.729-2, BRISTO MYERS SQUIBB CHILE, joined the hearing.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/708064).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1546983**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Ivan Paul** on **April 09, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **April 09, 2024 at 09:00 AM**, a significant meeting was led by **Ivan Paul**,  
serving as **Head of the Healthcare Network Management Division**.  
ğŸ‘¤ **Meeting Leader**  
**Ivan Paul** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: According to your request, Ms. Ana Jara, a professional from the Healthcare Network Management Division, will contact you. Contact 225740632 to request a link  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Paola Troncoso** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Clinical and economic impact of blood transfusions in chronic patients- Sustainability of the blood supply chain- Present a proposal to reduce transfusions in patients with myelodysplastic syndrome. The Undersecretary of Healthcare Networks is requested to participate.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/606206/697286).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1546997**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **June 05, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 05, 2024 at 02:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, with the following connection link: https://us02web.zoom.us/j/87868274744?pwd=NGdtRDd0MDVvMDhDSXdUWmhqOXJVUT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the Nivolumab value proposition in Hodgkin Lymphoma CM205The Department of Health Guarantees, ETESA and the Cancer Department are requested to participate*Topics covered:-Results and evidence of Nivolumab for Hodgkin Lymphoma are presented.*The following people join the audience:-Paola Romero, Rut 12.353.482-4, BRISTOL-Nancy Osses, Rut 12.841.917-9, BRISTOL-BÃ¡rbara Puga, Cancer Department-MINSAL-Pablo VÃ¡squez, Cancer Department-MINSAL-Katherine Cerda, ETESA-MINSAL-Andrea Guerrero, GES-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/715305).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1547196**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **May 22, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 22, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Link https://us02web.zoom.us/j/82655494084 Password 351338  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- General Aspects of LungUpdate of new treatment guidelinesUnmet medical needs in Lung CancerNew Therapies Available for Early Stages of Lung Cancer with Overall Survival Greater than 5 YearsThe meeting starts at 3:05 p.m.They present the topic of neoadjuvant nivolumab plus chemotherapy in resectable lung cancer, Checkmate 816 study.Dr. Kim joins at 3:20 p.m.Nathaly indicates that the presented scheme has been used in some centers, specifically in the eastern metropolitan health service and they consult with Dr. Kim on how this coverage could be extended nationwide. Dr. Kim indicates that he is aware of this information and that the use of nivolumab was supported by the evidence from the checkmate 816 study. Regarding coverage, he indicates that the Ministry of Health is in the process of updating the resolution on high-cost drugs (DAC) and of this process it is only possible to communicate that it is focusing on the review of drugs and drug indications of the last resolution with some additional ones, in which the budgetary impact is being reviewed. In addition, a second resolution is expected. Nathaly indicates that they conducted a cost-effectiveness study with an external consultant and the results show that this new scheme would provide cost savings when treating this subgroup of patients, incorporating nivolumab in the neoadjuvant setting, which could change the care algorithm. Ask Dr. Kim his position on this. Dr. Kim asks how the evaluation process of this cost-effectiveness was and Nathaly offers to hold a meeting to show the study and the methodology. Dr. Kim indicates that it is interesting to know the results of this study and that they should request the lobby from the Cancer Department, and from here other departments involved can be summoned. Nathaly agrees and indicates that she understands that new drugs are being evaluated for the DAC decree. Dr. Kim indicates that the existing drugs and indications for DAC are under evaluation. Lobby ends at 15:35.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/709298).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1551246**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Manuel Najera** on **April 12, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 50 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **April 12, 2024 at 12:00 AM**, a significant meeting was led by **Manuel Najera**,  
serving as **Head of Department of Ministerial Advisory**.  
ğŸ‘¤ **Meeting Leader**  
**Manuel Najera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The meeting will be held at the Ministry of Health in the DGDP Meeting Room, 1st floor, Monjitas 689.  
- **Format**: In person  
- **Duration**: 0 hours, 50 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Julian Jerez** â€“ Interest Manager, representing Sanofi Pasteur S.A.
- **Sergio Montero** â€“ nan, representing nan
- **HUGO DIBARBOURE ROSSINI** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Protocolary hearing requested for the 2024 Nirsevimab Campaign  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/517173/697749).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 50 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1551541**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **May 22, 2024**, focused on **preparation, processing, approval, modification, repeal or rejection of agreements, declarations or decisions of the national congress or its members, including committees.** and lasted for **0 hours, 25 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 22, 2024 at 03:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **preparation, processing, approval, modification, repeal or rejection of agreements, declarations or decisions of the national congress or its members, including committees.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/84570349890?pwd=Z01rSjZIdDBUNzdVbTgrNllINmJ5UT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 25 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, processing, approval, modification, repeal or rejection of agreements, declarations or decisions of the National Congress or its members, including committees.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Gonzalez** â€“ Lobbyist, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Dear Ms. Tania, From ROCHE Diabetes we would like to introduce our innovation in Continuous Glucose Monitoring (CGM) for patients with Diabetes M. 1 and 2. This innovation was recently presented at the ATTD in Europe (17th International Conference on Advance Technologies & Treatments for Diabetes) and today we want you to be informed of this new technology for patients. *Topics Covered: -Presentation of medical device for diabetic patients. *Joining the audience: -Katherine Cerda, ETESA-MINSAL-Andrea Vergara, Rut 14.119.014-8, ROCHE.-MarÃ­a PÃ­a CalderÃ³n, Rut 16.368.619-K, ROCHE  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/709647).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 25 minutes** and concluded with actionable insights regarding preparation, processing, approval, modification, repeal or rejection of agreements, declarations or decisions of the national congress or its members, including committees..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1551775**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Christian Garcia** on **April 10, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 10, 2024 at 12:00 PM**, a significant meeting was led by **Christian Garcia**,  
serving as **Head of Epidemiology Department**.  
ğŸ‘¤ **Meeting Leader**  
**Christian Garcia** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Mariella Francesca Parodi Soza** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Sebastian Guerrero** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Jessica RUT Jassir Felfle** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Prevention for the elderly population regarding RSV  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/458386/696992).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1552384**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **May 23, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 33 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 23, 2024 at 03:02 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Need help? Join the meeting now Meeting ID: 287 477 744 851 Passcode: 5zSeTh ________________________________________  
- **Format**: Videoconference  
- **Duration**: 0 hours, 33 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Oriana Alderete** â€“ Interest Manager, representing Tencofarma Pharmaceutical Industry
- **Tomas Arevalo** â€“ Interest Manager, representing Tencofarma Pharmaceutical Industry
- **Carmen Gamboa** â€“ Interest Manager, representing Tencofarma Pharmaceutical Industry
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Review of the value proposition for the DAC process of the abemaciclib product, a cyclin inhibitor for the indication of RH+/HER2- breast cancer  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/709651).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 33 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1553444**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Manuel Palominos Malbran** on **April 16, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **April 16, 2024 at 04:30 PM**, a significant meeting was led by **Manuel Palominos Malbran**,  
serving as **Head of Communications-SSP**.  
ğŸ‘¤ **Meeting Leader**  
**Manuel Palominos Malbran** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by the Head of Communications of the Office of the Undersecretary of Public Health. The hearing will be held online and the link will be sent to your email. Telephone: 225740407  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Torrealba Diaz** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Juan Carlos Mendez** â€“ Interest Manager, representing nan
- **Sandra Pino** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Maria Sol Plamenatz** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- The reason for the request is to formally introduce ourselves to you and offer ourselves as collaborators in the dissemination of the Winter 2024 Campaign. We recognize the importance of this initiative in the promotion of public health and we are committed to contributing our resources and experience to ensure its success. We would like to share our ideas and proposals on how we can effectively collaborate in the dissemination of this campaign and how Boehringer Ingelheim can complement your efforts to achieve greater reach and effectiveness in protecting health during the winter season. They were received by the Head of Communications of the Office of the Undersecretary of Public Health, Manuel Palominos. Topics discussed, projects that go beyond the commercial, such as health promotion and actively contributing to the immunization campaign.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/666407/698905).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1554063**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **May 14, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **May 14, 2024 at 10:00 AM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Need help? Join the meeting now Meeting ID: 291 485 962 541 Passcode: 2GyQUv  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ximena Paredes** â€“ Interest Manager, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Participants:- Felipe Vera- Tamara Doberti- NicolÃ¡s AmenÃ¡barTopic: They present a proposal for risk-sharing agreements for risdiplam that combines the capping model and the clinical outcome model. They also report initial results on studies with patients who have used other treatments for SMA and who are currently in studies with Risdiplam. The proposal considers the admission of patients at an early age and also the incorporation of patients who are currently in studies with Risdiplam. They agree to send the proposal and the presentation made.Life Cycle Department  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/723589).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1557189**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Ivan Paul** on **May 23, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 23, 2024 at 12:00 PM**, a significant meeting was led by **Ivan Paul**,  
serving as **Head of the Healthcare Network Management Division**.  
ğŸ‘¤ **Meeting Leader**  
**Ivan Paul** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Time: May 23, 2024 12:00 PM Santiago Enter Zoom Meeting https://us02web.zoom.us/j/83883216792 Meeting ID: 838 8321 6792 Passcode: 335818  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ximena Paredes** â€“ Interest Manager, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Implementation of the Hemophilia-Hemlibra Ministerial Program  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/606206/712610).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1558521**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **May 08, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 08, 2024 at 03:30 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received virtually by Dr. Sung Kim, Head of the Comprehensive Management of Cancer and Other Tumors Department. The connection link will be sent by email. Secretary's phone: 2574 0501  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Paola Troncoso** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Attendants: Natalie Van De Wyngard Bristol Myers Laboratory, Rut: 8.003.051-7, Paola Troncoso Bristol Myers Laboratory, Rut: 12.353.482-4, Carolina ZÃ¡rate Garrido Department of Comprehensive Management of Cancer and Other Tumors. Rut: 15.839.195-3Meeting starts at 15:45. Attendees introduce themselves and request their RUTs. Natalie indicates that they are requesting this lobbying instance to present technologies focused on criteria of: - Unprotected or uninsured patient groups - That have evidence of new biomarkers - That present clinical benefits and/or improvements in quality of life. Carolina ZÃ¡rate mentions that this lobbying instance is of an expository nature from the industry to MINSAL, and that the channel for making inquiries is through the transparency law. Natalie indicates that it is important to present new treatment technologies to the Cancer Department, since in other Lobby instances with DIPLAS or DAC, they have indicated that it is this Department that defines the prioritization criteria for the evaluation of new technologies. She also indicates that it is very important for them to schedule a lobby meeting with the Head of Department, Dr. Sung Kim to present these new therapies. Paola Troncoso begins presentation of the drug luspatercep in transfusion-refractory myelodysplastic syndrome. The epidemiology and results of phase II and phase 3 clinical studies are shown. It indicates that it can increase transfusion independence in a group of patients and shows the possible savings in health expenses by reducing the need for transfusions in patients.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/705900).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1562962**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **June 04, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 04, 2024 at 04:00 PM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Need help? Join the meeting now Meeting ID: 235 085 595 60 Passcode: aUAkVt  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Peter Alonso** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Attendees: - Tamara Doberti- MarÃ­a JosÃ© GuzmÃ¡n- Melanie Paccot- Pamela LlantÃ©n- Felipe VeraThey present the benefits of neonatal screening, including SMA screening.It is reported that a budget expansion project for expanded neonatal screening of the 26 pathologies was effectively presented, as well as another budget project for SMA screening and confirmation. It is reported that we are in the first stage of the budget discussion and that the support and proposals of the laboratory will be requested in the case of continuing to advance in the budget expansion. They will send available information on the Brazilian research project and the results of clinical studies with Zolgensma and the benefit of timely research, in addition to sharing contact information for experts in SMA screening. They invite people to participate in a discussion in Brazil on the neonatal SMA screening project that they have set up. As a Ministry, we are committed to exploring the options for public-private collaboration. Life Cycle Department  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/723293).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1564287**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **June 12, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 12, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/83139798222?pwd=eXVYZnR3dHBxS0hHZ29kMDNVMjZKUT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Daniela Tamayo** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Alvaro Sepulveda** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Maria Paula Collados** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- meeting is requested with the head of the Department of Health Technology Assessment and Evidence-Based Health (ETESA/SBE) to present data and background information regarding the treatment of breast cancer with Olaparib (LYNPARZA) and to ask questions about the upcoming DAC process.*Topics discussed:-Presentation of Olaparib data for breast cancer.*Katherine Cerda Figueroa, ETESA-MINSAL, joins the audience.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/715778).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1564519**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **May 20, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 20, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join the meeting now Meeting ID: 299 384 723 745 Passcode: jzTshd  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Maria Pons** â€“ Interest Manager, representing nan
- **Patricia Morvillo** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- LRS process status 2025  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/708994).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1564723**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **June 05, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 05, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join the meeting now Meeting ID: 272 255 693 113 Passcode: gsvLzM  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Torrealba Diaz** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Renan Fuentealba** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- We request a meeting in order to follow up on the processes of the Ricarte Soto Law and GES of 2025  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/723924).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1564865**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **June 12, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 12, 2024 at 03:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, phone number 225740458. Connection link: https://us02web.zoom.us/j/81095504297?pwd=cVlMWFczbVVmMFJOSFdaeTc5M1hpQT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Paola Troncoso** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the proposal to evaluate the DAC coverage of the drug Oral Azacitidine for the maintenance treatment of acute myeloid leukemia*Topics covered: -Presentation of Oral Azacitidine for AML and consultation on incorporation into the DAC.*Andrea Guerrero Ahumada, GES-MINSAL, joins the audience  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/715780).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1566300**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **May 15, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 15, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Paola Troncoso** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- General aspects of Acute Myeloid LeukemiaUnmet medical needs in AMLUpdate of AML Clinical GuidelinesMaintenance therapy in AML, for evaluation prioritization;Meeting starts at 3:00 p.m. Attendees introduce themselves:Natalie Van De Wyngard Bristol Myers Laboratory, Rut: 8,003,051-7Paola Troncoso Bristol Myers Laboratory, Rut: 12,353,482-4Pablo VÃ¡squez Lara Dept. of Comprehensive Management of Cancer and Other Tumors. Rut: 16,355,478kNatalie indicates that the presence of the head of the Department of Comprehensive Management of Cancer and Other Tumors, Dr. Sung Kim, was explicitly requested, who referred representation to a professional from the department. Exhibitors decide not to present and to ask for a new lobby. Information is requested regarding the functioning of the department and Clinical Practice Guidelines. It is noted that the lobbying session is expository, so queries must be made in accordance with the transparency law. The meeting ends at 3:15 p.m.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/708689).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1566329**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **May 15, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 15, 2024 at 03:30 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- General aspects of renal cancerUnmet medical needs in renal cancerRecommendation for the use of Ipilimumab+Nivolumab with 8-year follow-up and OS. Comparative vs Sunitinib OS, PFS, DIR and HRQoL//Participants:Francisca Plaza, Cancer DepartmentNathaly Van De Wyngard; RUT: 8,003,051-7Eduardo Ãlvarez; RUT: 18,577,548-8A presentation is made about the Nivolumab+Ipilimumab indication in intermediate/high risk renal cancer. The advantages it has as a first-line therapy and the favorable recommendations in the different guidelines (national and international) are highlighted. They comment that in several countries this indication is covered. In Chile, although Nivolumab is covered in DAC for second-line treatment, it is not for first-line. They request that it be recorded that they need to identify with whom they should speak so that these medications are included in the evaluation and prioritization for their inclusion in some coverage guarantee. They also mention that it be recorded that they have requested that the Head of the Cancer Department be in the lobbies, since DIPLAS informed them that the Cancer Department is the one who prioritizes.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/708341).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1567702**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **June 19, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 19, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, phone number 225740458. Connection link: https://us02web.zoom.us/j/82870969913?pwd=Y3ZKRHY4TGJVQlhRV0lJS0xCaEpvUT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Eduardo Sebastian Olivares Saavedra** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Alvaro Sepulveda** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Cecilia Panzone** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Luciana Di Lemme** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- meeting is requested with the head of the Department of Health Technology Assessment and Evidence-Based Health (ETESA/SBE) to present data and background information regarding the treatment of biliary tract cancer with Durvalumab (IMFINZI) and to make inquiries about the upcoming DAC process.*Topics discussed:-Presentation of Durvalumab for the treatment of biliary tract cancers.*Those who did not attend the hearing:-Eduardo Olivares Saavedra, AstraZeneca Chile-Ãlvaro SepÃºlveda, AstraZeneca Chile-Luciana Di Lemme, AstraZeneca Chile*Those who joined the hearing:-Pablo NuÃ±ez, Astrazeneca Chile-Katherine Cerda, ETESA-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/717650).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1567742**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **June 19, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 19, 2024 at 03:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, phone number 225740458, contact email: yasna.aguilera@minsal.cl. Connection link: https://us02web.zoom.us/j/87233509763?pwd=eTZVUmhEL1lVVGtyZ0Z2MXl  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Alvaro Sepulveda** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Cecilia Panzone** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Luciana Di Lemme** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Daniel Sutovsky** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- meeting is requested with the head of the Department of Health Technology Assessment and Evidence-Based Health (ETESA/SBE) to present data and background information regarding the treatment of Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma with Acalabrutinib (CALQUENCE) and to make inquiries about the upcoming DAC process.*Topics discussed:-Presentation of a drug for chronic leukemia.*Not attending the hearing:-Luciana Di Lemme, Astrazeneca Chile*Joining the hearing:-Katherine Cerda, ETESA-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/717652).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1569026**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **June 26, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **June 26, 2024 at 09:00 AM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/82853514536?pwd=d0JhYWJsM1lCQ3BPbnZTYnF4MVFlQT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Oviedo** â€“ Lobbyist, representing Merck SA
- **Diego Rojas** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- .- Proposal for Improvement of the Technical and Economic Treatment Standard for Head and Neck Cancer with Cetuximab*Topics covered:- Bladder cancer, presentation of Avelumab, immunotherapy for urothelial cancer were discussed at this hearing.- Ms. Andrea Guerrero Ahumada, GES-MINSAL, joins the Hearing.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/719286).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1569164**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **June 26, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **June 26, 2024 at 09:30 AM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/81565042256?pwd=bkNwelFjTmxrc1Q1ZFRtOGZYZmNOdz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Oviedo** â€“ Lobbyist, representing Merck SA
- **Diego Rojas** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Improvements in technical and economic treatment standards for bladder cancer, to consider pathology in DAC*Topics discussed:-Head and neck cancer was discussed at this hearing.*Mr. Ramiro CofrÃ© CofrÃ©, GES-MINSAL, joined the hearing  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/719287).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1569234**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Elizabeth Lopez** on **May 17, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **May 17, 2024 at 10:00 AM**, a significant meeting was led by **Elizabeth Lopez**,  
serving as **Head of the Immunization Department**.  
ğŸ‘¤ **Meeting Leader**  
**Elizabeth Lopez** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: They will be contacted by the PNI- DIPRECE Telephone: 25688128  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ana Karachon** â€“ Interest Manager, representing Pfizer Chile S.A.
- **Lorena Vega** â€“ Interest Manager, representing nan
- **Norka Napuri** â€“ Interest Manager, representing nan
- **Sol GoÃ±i** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the Pfizer laboratory and available vaccines.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/678098/720655).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1570736**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Elizabeth Lopez** on **July 17, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **July 17, 2024 at 11:00 AM**, a significant meeting was led by **Elizabeth Lopez**,  
serving as **Head of the Immunization Department**.  
ğŸ‘¤ **Meeting Leader**  
**Elizabeth Lopez** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: A face-to-face meeting is held to learn about the Sinovac laboratory project  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jorge GOLDENBERG** â€“ Interest Manager, representing Extend
- **Barbara Orellana** â€“ Interest Manager, representing nan
- **Weining Meng** â€“ Interest Manager, representing nan
- **Yichen Song** â€“ Interest Manager, representing nan
- **Run Chen** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presenting the Sinovac project to the new director of the National Immunization Program  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/678098/731024).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1570957**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **July 10, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **July 10, 2024 at 02:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/83735473745?pwd=aEI3dDJkcFMwKy84L0hZMXg2MVZldz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Paola Troncoso** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Clinical and economic impact of blood transfusions in chronic patients- Present proposal to treat patients with Myelodysplastic Neoplasia.- Request evaluation for the inclusion of Luspatercept in DAC. It is requested that you participate in the ETESA meeting, Health Guarantees Department, Cancer Department. *Topics discussed:- Presentation of medication to treat anemia in myelodysplastic diagnosis.- Nathaly Van De Wyngard-BRISTOL does not attend the hearing- The following people join the hearing: Andrea Guerrero-GES-MINSAL Victoria Hurgado-ETESA-MINSAL Andrea Peralta-DIPRECE-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/723552).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1572272**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Susana Fuentealba** on **June 14, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **June 14, 2024 at 11:00 AM**, a significant meeting was led by **Susana Fuentealba**,  
serving as **Head of the Department of Clinical Processes and Hospital Management-SRA.**.  
ğŸ‘¤ **Meeting Leader**  
**Susana Fuentealba** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom Link https://us02web.zoom.us/j/85708199881 Password 258002 With the Host Role you can apply security, record, activate the waiting room, close the microphones and manage the meeting. Password to claim the host role 860848  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Vega** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- A meeting is requested to present an alternative to the ministerial program for growth hormone deficiency with the aim of ensuring treatments in the program.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/666957/747076).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1573668**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **September 05, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 05, 2024 at 03:30 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone: 225740458, with the following connection link: https://us02web.zoom.us/j/81565102541?pwd=MnQ2TzhKZEZSMkROL1VjSjNtVHhmQT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Heise** â€“ Interest Manager, representing nan
- **Maria Verdugo** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Within the framework of the process of preparing and updating new resolutions for the National Reimbursement System, we request this hearing to learn about the status of High Cost Drugs (DAC)  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/738064).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1576934**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **July 24, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 28 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **July 24, 2024 at 03:30 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/86907744330?pwd=Qm9FelZWcDVPMDg1U0N5WlNmRzZ3Zz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 28 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **John Corona** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Within the framework of the request for inclusion of the subcutaneous presentation of Natalizumab, we respectfully request to meet with you, as well as with the head(s) of ETESA, Katherine Cerda and the Researcher Catherine de la Puente, as well as with the Professor of the Ricarte Soto Law Coordination Office, Joan Cornejo, and/or with whomever you deem appropriate, in order to be able to show you the application device in situ and in this way, provide more elements that support the evaluation.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/726746).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 28 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1577459**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Carolina Isla Meneses** on **May 23, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 23, 2024 at 12:00 PM**, a significant meeting was led by **Carolina Isla Meneses**,  
serving as **Head of Hospital Pharmacy Processes Unit-SRA.**.  
ğŸ‘¤ **Meeting Leader**  
**Carolina Isla Meneses** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Nuns 565, 9th floor  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jose Allemant** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Addressing Covid/Flue Testing and its benefits in terms of efficiency.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/666971/748170).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1577758**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **July 30, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **July 30, 2024 at 10:00 AM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: A connection link will be sent to the indicated email address: 25740533  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Christian Morales** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Alejandra Cisneros** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Hemant Vijayran** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Tamara Doberti- Emilia Reyes- Felipe Vera- Macarena Moya- Christian Morales- Pamela LlantÃ©n- Hemant VijayranThis lobby corresponds to the follow-up of the lobby meeting we had in May, on eculizumab and ravulizumab. The MINSAL reports that we have 12 patients under judicial review with eculizumab and 12 with ravulizumab and that we cannot change the judicial rulings, that we must explore the power to allocate resources to change their treatment. The laboratory mentions that eculizumab is not registered in Chile and that in the future they will not produce it because ravulizumab is clearly superior in treatment. MINSAL: we promise to coordinate a meeting with FINASA to evaluate the access alternatives and to be able to make the change. Laboratory: they promise to present access strategies and economic offers.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/733176).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1580269**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **July 31, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **July 31, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone: 225740458, with the following connection link: https://us02web.zoom.us/j/87536868524?pwd=cnhmMXdXM1ZWN0RBZmZpOVNnVm84UT09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Sonia Torrealba** â€“ Interest Manager, representing Novartis Chile S.A.
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up to the coverage processes (GES, DAC and LRS) and review of the direct treatment renewal process for palbociclib (ID 621-278-SC22).-*Topics discussed:-Norvatis asks about the status of progress on the DAC-GES and LRS processes.-The following people join the audience:MarÃ­a JosÃ© GuzmÃ¡n, Rut 17.408.059-3, NORBATISAndrea Guerrero and Hugo OssandÃ³n, GES-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/729494).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1581870**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **July 24, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **July 24, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/83168530360?pwd=Kzlvd0xvWWhYZHhmMmZSNER0bWZydz09  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Amanda Caetano Batista** â€“ Interest Manager, representing nan
- **Renzo Wong** â€“ Interest Manager, representing nan
- **Paula Nahuelhual** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- PRESENTING MEDICINES FOR TRIPLE NEGATIVE BREAST CANCER.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/726745).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1583135**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Elizabeth Lopez** on **June 11, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 11, 2024 at 03:00 PM**, a significant meeting was led by **Elizabeth Lopez**,  
serving as **Head of the Immunization Department**.  
ğŸ‘¤ **Meeting Leader**  
**Elizabeth Lopez** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Videoconference via zoom  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Julian Jerez** â€“ Interest Manager, representing Sanofi Pasteur S.A.
- **HUGO DIBARBOURE ROSSINI** â€“ nan, representing nan
- **Florence Esquivel** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Aspects related to immunization with monoclonal antibody against RSV for the year 2025. Hexavalent vaccine, new presentation with prefilled syringe in a format of 10 syringes per box. Future vaccination strategies in Chile.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/678098/720650).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1585174**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **June 26, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 26, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Santiago  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Gonzalez** â€“ Lobbyist, representing Roche Chile Limited
- **Claudia Alejandra Morris Carmona** â€“ Interest Manager, representing Roche Chile Limited
- **Fernanda Rivera** â€“ Interest Manager, representing Roche Chile Limited
- **Juan Herrera** â€“ nan, representing nan
- **Stephanie Cifuentes** â€“ nan, representing nan
- **Gina Merino** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Summary of HPV acquisition processes in the public health care network, presentation of HPV collection methods (taken by professionals and self-collection), results of the HPV incorporation course in PHC. Consultations are held and new lobbying is requested to specifically develop topics related to self-collection of HPV.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/718818).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1585884**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **July 17, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **July 17, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Via Zoom.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Carlos Dufeu** â€“ Interest Manager, representing Merck Sharp and Dohme IA LLC
- **Carmen Gamboa** â€“ Interest Manager, representing Tencofarma Pharmaceutical Industry
- **Reinaldo Cornejo** â€“ Interest Manager, representing Merck Sharp and Dohme IA LLC
- **Francisca Plaza** â€“ nan, representing nan
- **Andrea Peralta De la Rosa** â€“ nan, representing nan
- **Carlos Dufeu** â€“ Interest Manager, representing Merck Sharp and Dohme IA LLC
- **Carmen Gamboa** â€“ Interest Manager, representing Tencofarma Pharmaceutical Industry
- **Reinaldo Cornejo** â€“ Interest Manager, representing Merck Sharp and Dohme IA LLC
- **Francisca Plaza** â€“ nan, representing nan
- **Andrea Peralta De la Rosa** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- presentation is made regarding the general work of the company Tecnofarma, its positioning in Latin America and its portfolios in various pathologies, including general medicine and oncology. Later, greater emphasis is placed on 4 medications: Verzenio (Abemaciclib) in breast cancer, Vectibix (Panitumumab) in colon cancer, Blincyto (Blinatumumab): in ALL and Naxitamab (Danyelza) in neuroblastoma. For the latter, it is mentioned that it will soon be submitted for registration at ISP. Carmen presents about Versenio (Abemaciclib) in breast cancer, CDK4/6 inhibitor. The Monarch 3 and 2 studies support the use in first and second line treatment in stage IV breast cancer, respectively. For its part, the Monarch E study accredits the use of this drug in early breast cancer. The lobbyists comment that this drug is in DAC for people with metastatic breast cancer; However, they would also like to extend their guarantee for early-stage cancer. The information is appreciated and we request that you send this material for review by the National Agency for Cancer Prevention and Control Department. It is also clarified that it is not possible to provide additional information during the lobbying process.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/724612).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1589907**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **August 14, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 37 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 14, 2024 at 03:13 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Link https://us02web.zoom.us/j/88468885151 Password 363637  
- **Format**: Videoconference  
- **Duration**: 0 hours, 37 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the economic evaluation of the inclusion of NIVOLUMAB in the neoadjuvant treatment of lung cancer in the Chilean system. LENZ Consulting is presenting. Please schedule a meeting in MAY preferably or the first week of July. â€¢ Eduardo Ãlvarez 18577548-8, Rony Lenz 8.692.132-4, and Nancy Oses Bustos 12849967-9 will attend. Miguel Paredes and Sung Kim will connect from ANACAN. â€¢ Rony Lenz will present an economic analysis of nivolumab for the neoadjuvant treatment of non-small cell lung cancer (IB to IIIB resectable) in the Chilean public health system. Refers to nivolumab+QMT excluding EGFR, ROS1 and ALK mutations, plus positive PD-L1.â€¢ CheckMate 816: neoadjuvant nivolumab+QMT presents 32% better performance than QMT, which is reflected in the survival curve. Distant recurrence is also reduced from 22% to 10%.â€¢ 4,800 lung cancer patients have been seen annually since implementation of GES, which coincides with the demand estimate for Chile.â€¢ Without nivolumab neoadjuvant treatment, it costs $7.315MM to treat 359 INT patients with QMT and surgery, including treatment of locoregional and distant recurrences.â€¢ With nivolumab neoadjuvant treatment, it costs $6.852MM to treat the same number of patients with QMT plus nivolumab and surgery, considering a decrease in adjuvant QMT and locoregional and distant recurrence.â€¢ Neoadjuvant treatment with QMT without nivolumab is $310MM for 359 patients.â€¢ Results will be sent by email. Publication is pending.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/731964).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 37 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1590494**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Susana Fuentealba** on **May 23, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 23, 2024 at 12:00 PM**, a significant meeting was led by **Susana Fuentealba**,  
serving as **Head of the Department of Clinical Processes and Hospital Management-SRA.**.  
ğŸ‘¤ **Meeting Leader**  
**Susana Fuentealba** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Nuns 565, 9th floor  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Julio Jimenez** â€“ Interest Manager, representing Recalcine Laboratory
- **Nicholas Pizarro** â€“ Interest Manager, representing Etcheberry Group
- **Cyrille Schroeder** â€“ Interest Manager, representing nan
- **Daniel Horan** â€“ Interest Manager, representing nan
- **Javiera MuÃ±oz** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of covid/flu test  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/666957/747080).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1590519**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Carolina Isla Meneses** on **May 23, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 23, 2024 at 12:00 PM**, a significant meeting was led by **Carolina Isla Meneses**,  
serving as **Head of Hospital Pharmacy Processes Unit-SRA.**.  
ğŸ‘¤ **Meeting Leader**  
**Carolina Isla Meneses** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Nuns 565, 9th floor  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Julio Jimenez** â€“ Interest Manager, representing Recalcine Laboratory
- **Nicholas Pizarro** â€“ Interest Manager, representing Etcheberry Group
- **Cyrille Schroeder** â€“ Interest Manager, representing nan
- **Daniel Horan** â€“ Interest Manager, representing nan
- **Javiera MuÃ±oz** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Covid/flu test presentation.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/666971/748173).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1590542**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Carolina Isla Meneses** on **May 23, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **May 23, 2024 at 12:00 PM**, a significant meeting was led by **Carolina Isla Meneses**,  
serving as **Head of Hospital Pharmacy Processes Unit-SRA.**.  
ğŸ‘¤ **Meeting Leader**  
**Carolina Isla Meneses** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Nuns 565, 9th floor  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Julio Jimenez** â€“ Interest Manager, representing Recalcine Laboratory
- **Nicholas Pizarro** â€“ Interest Manager, representing Etcheberry Group
- **Cyrille Schroeder** â€“ Interest Manager, representing nan
- **Daniel Horan** â€“ Interest Manager, representing nan
- **Javiera MuÃ±oz** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Covid/flu Test Presentation.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/666971/748175).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1593170**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **August 14, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 15 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 14, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/83708719460?pwd=t8XcrsJtRiwk4bWN3oooyaHAQvbXUW.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 15 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Pablo de la Llera** â€“ Interest Manager, representing DNPV Lawyers SpA
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up of request submitted by the MINSAL parts office, requesting the incorporation of two new representations of ORFADIN, which have no economic impact on the budget.*Topics discussed:-Follow-up on previous meeting to incorporate drug in new presentations without budgetary impact.-The changes were proposed for the LRS modifying decree.*The following join the hearing.-Igor Correa, Rut 12,254,536-9, Innovative Medicines SA-Fabiola Rosso, GES-MINSAL-Katherine Cerda, GES-MINSAL-Patricia Gamboa, DIGERA-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/732122).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 15 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1595229**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Juan Collao** on **June 14, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 40 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **June 14, 2024 at 11:00 AM**, a significant meeting was led by **Juan Collao**,  
serving as **Head of the Department of Pharmaceutical Policies and Regulations, Health Providers and Complementary Medicines.**.  
ğŸ‘¤ **Meeting Leader**  
**Juan Collao** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be assisted by Mr. Collao.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 40 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ximena Paredes** â€“ Interest Manager, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Current regulations on approval of biological drugsTOPICS ADDRESSED AT THE MEETING:It informs that it requested a meeting to review regulatory processes associated with the approval of orphan drugs in Chile, specifically for the approval of its biotechnological product "Glofitamab" for the treatment of patients with "Diffuse lymphoma"; this due to the delay in granting its health registration and on the recommendation of ISP, to evaluate with MINSAL potential prioritizations for its authorization (References No. RF 1857723 and No. RF 1857740, both entered in May 2022).It indicates that according to current regulations, the ordinary registration regulatory processes - to which biotechnological molecules are subjected - should take 6 months, but this does not happen in reality, there being a longer period for regulatory approval and there being no clear administrative route to date that allows priority evaluation; In their view, the latter aspect is an opportunity for regulatory improvement to make processes more efficient and improve patient accessibility to more cost-effective pharmacological treatments. They state that they have studied the subject and that for 60% of the approved health registrations there is an evaluation and approval time of 22 to 32 months, according to the "WAIT" report, developed by "Fifarma" and "IQVIA", which shows that the regulatory approval processes in Chile are one of the longest in Latin America, which delays accessibility to patients. They require the prioritization and acceleration of the regulatory approval of "Glofitamab", since it addresses the therapeutic treatment where there would be no major pharmacological alternatives; while in Non-Hodgkin B-Cell Lymphoma 65% of patients are cured with current therapies, but products are required for patients who are resistant to established therapies and who fail in their initial treatments; There is a need that would be covered by â€œGlofitamabâ€, as a third-line product, which has shown a good therapeutic response immediately after treatment and which is significantly maintained afterwards, giving complete and long-lasting remissions beyond the end of treatment. They add to the above, that the referred product has already been authorized by FDA/USA and EMA/Europe, during the year 2023 and that to date there are more than 2,100 patients treated worldwide since the start of its commercialization (in addition to the patients who were treated in the respective clinical trials). Additionally, it reports that in Chile some patients have managed to receive the therapy through a coverage for "compassionate use" (8 patients), while the drug has been requested by some local doctors in a special way because it is an orphan disease. They point out that, according to what was reported by ISP, the only option to prioritize the evaluation of the sanitary registration of "Glofitamab" is for the MINSAL to establish the prioritization, by resolution, by application of the registration abbreviation referred to in article 51Â° of DS MINSAL NÂ° 3/2010. They propose opportunities for improvement of the current regulation and thus have effective mechanisms for registrations of orphan drugs and therapies advanced, such as:- Allowing prioritization of evaluation of orphan drug registration, recognized by high surveillance authorities.- Extending the application of the accelerated registration procedure to biotechnological medicines, these being relevant and latest innovation products for diseases of health importance. In the case of "Glofitamab", they also propose the possible application of article 54Â° of DS MINSAL No. 3/2010. It is reported that as a result of regulatory modifications made to art. 51Â° of DS MINSAL No. 3/2010 (year 2020), the issuance of a ministerial resolution to shorten the registration procedure for products included in MINSAL plans and programs or in the National Drug Formulary is no longer necessary; but that in any case such mechanism would not be applicable to the case under review. Likewise, it is indicated that the registration acceleration route would be only prospective and its extension to biotechnological medicines is under study. However, it is reported that the MINSAL may be formally requested to urgently have the product, taking into account its usefulness in clinical cases where there are no other treatment options.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/622861/716244).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 40 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1597797**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **August 20, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 20, 2024 at 04:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/84392944766?pwd=5vwBuOPQVLVeZlgM0JTamSNQaBqfuS.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up to hearing AO001AW1498135 Nivolumab in Gastric Cancer CM649+*Topics covered_-The technology is presented again and the DAC process that is beginning is explained. Nathaly Van de Wyngard does not attend, because she no longer works at BMS.-The following people join the hearing: Andrea Guerrero Ahumada, GES-MINSAL Katherine Cerda Figueroa, ETESA-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/732755).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1597985**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **August 20, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 20, 2024 at 04:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/85930777631?pwd=LJzNBz30ZQ3maeGk9xg0rpCND6brCi.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up Lobby AO001AW1507322 of 2/28/24 Nivolumab in 1L CM214 renal cancer*Topics discussed:-The technology is presented again and the new DAC process that is beginning is explained.-Nathaly Van de Wyngard does not attend, because she no longer works at BMS.-The following people join the audience:Andrea Guerrero Ahumada, GES-MINSALKatherine Cerda Figueroa, ETESA-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/732754).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1598016**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **August 28, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 28, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/81601503702?pwd=eYRyk2h4auJST1hCTDcvn5FGPJtBaJ.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up Lobby AO001AW1485078 of 3/6/24 Regarding Nivolumab in Neoadjuvant Lung Cancer CM816*Topics discussed:-Follow-up to previous meeting for Nivolumab for lung cancer.-Proposed target population lung cancer PDL1-Nathaly Van De Wyngard does not attend the hearing, because she no longer works at BMS.-The following people join the hearing: Andrea Guerrero Ahumada, GES-MINSAL Katherine Cerda, ETESA-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/735356).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1600618**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **August 09, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **August 09, 2024 at 11:00 AM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Need help? Join the meeting now Meeting ID: 278 436 815 205 Passcode: mwwHxU  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **John Corona** â€“ Interest Manager, representing nan
- **Claudio Covini** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Guests: - Carolina de Pablo - Claudio Covini- Cristian Matamala - Emilia Reyes- JoaquÃ­n Pedre - JoaquÃ­n Tagle - Juan Corona - Pamela LlantÃ©n - Ramiro Cofre and Tamara Doberti. Biogen presents a risk profile for a possible shared risk agreement, they ask questions about what risk profile we need to describe from the MINSAL. The response is that specifically in AME1 we are interested in the functional results and possible combinations of therapies available for AME 1. Biogen leaves questions in chat: Would currently judicialized patients move to the possible coverage scheme? Or would they continue with their current status and the coverage scheme be for new patients exclusively? ïƒ This is part of what could be discussed as part of the ARC, effectively incorporating patients already in treatment could make it more complex to establish compliance with clinical milestones. What is the current coverage criterion for a new patient with SMA type 1 who, having been proposed by their treating physician, is not a candidate for gene therapy? ïƒ  Currently, MINSAL only has the acquisition and financing strategy for gene therapy with onasemnogen abaperbovec. How does the Office of Complex Chronic Conditions and Rare Diseases of DIPRECE plan to evaluate results once therapy has started? Would it be exclusively through the AD HOC Commission currently active? Evaluation by an external entity agreed upon by both parties? Would a commission be formed especially for the evaluation of results? ïƒ  The best way is being explored with other countries. In general, a follow-up protocol must always be established with the milestones established in the ARC, which would be evaluated by a committee made up of people external to MINSAL. But it is also part of the ARC proposal that can be built. What is the time horizon for implementing the ARC? ïƒ  We are currently working on presenting the institutional ARC proposal to the Authority as part of an ARC policy. Then we would move forward with the different providers that could make ARC.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/733878).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1600830**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Albagli** on **June 28, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **June 28, 2024 at 11:00 AM**, a significant meeting was led by **Andrea Albagli**,  
serving as **Undersecretary of Public Health**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Albagli** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: They will be contacted by the Office of the Undersecretary of Public Health. Telephone: 225740407  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jorge GOLDENBERG** â€“ Interest Manager, representing Extend
- **Barbara Orellana** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Sinovac Project in ChileSinovac AssistantsJorge Goldenberg, Christian RamÃ­rez and Barbara Orellana.MinsalUndersecretary of HealthAndrea AlbagliElizabeth Lopez, MarÃ­a Soledad Martinez and Sara Correa.Subject: "The company representatives appreciate the joint work carried out for the last purchase of vaccines, which was successful. They express their interest in continuing to move forward with the creation of a vaccine production plant in Chile and its respective tender"  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/557884/719588).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1601173**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Elizabeth Lopez** on **July 11, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **July 11, 2024 at 10:00 AM**, a significant meeting was led by **Elizabeth Lopez**,  
serving as **Head of the Immunization Department**.  
ğŸ‘¤ **Meeting Leader**  
**Elizabeth Lopez** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: anamaria.karachon@pfizer.com  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ana Karachon** â€“ Interest Manager, representing Pfizer Chile S.A.
- **NORKA NAPURI** â€“ Interest Manager, representing nan
- **Maria Mladineo** â€“ Interest Manager, representing nan
- **Juan Francisco Falconi** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation by the Pfizer laboratory of scientific information corresponding to updated pneumococcal vaccine against RSV for vaccination of pregnant women and the adult population, in addition to the vaccine against COVID-19.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/678098/731029).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1602077**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **September 04, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 04, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Link to join the session: https://us02web.zoom.us/j/86751687583 Password: 529856  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Nathaly Van De Wyngard** â€“ Interest Manager, representing Merck SA
- **Nancy Oses** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Eduardo Alvarez** â€“ Interest Manager, representing nan
- **Francisca Plaza** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Eduardo Alvarez, from BMS, made a presentation on the Checkmate 274 study. The PDL1 evaluation (immunohistochemistry) was consulted in relation to the value of the study. It was mentioned that the exact value of the study is unknown, but that BMS has a patient support program that finances this test. Nancy commented that a value proposal will be sent for the GES of bladder cancer, with the objective of including Nivolumab. In addition, she indicated that there is the possibility of including units at no cost for patients in the public system. This same proposal was raised in previous lobbies with DIPLAS.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/737578).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1605519**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **September 05, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 05, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: A Teams email will be sent to Maria Pons' email.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Maria Pons** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Dear Sirs, on May 20, 2024, a lobby meeting was held with document AO001AW1564519 with Andrea Guerrero and Hugo OssandÃ³n. At this meeting, a query was made about the feasibility of evaluating some technology for an existing pathology in Law 20,850 that offers savings to the system but that was not requested by any patient group or medical society in the repository of citizen requests. This meeting request is to follow up on the response to the query, which remained to be found out by those attending.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/738062).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1605692**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Carmen Maria Aravena Cerda** on **June 24, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hour, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **June 24, 2024 at 09:30 AM**, a significant meeting was led by **Carmen Maria Aravena Cerda**,  
serving as **Head of Primary Care Division-SRA**.  
ğŸ‘¤ **Meeting Leader**  
**Carmen Maria Aravena Cerda** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: audience received by Dr. Marcela Rivera, DIVAP advisor via zoom.  
- **Format**: Videoconference  
- **Duration**: 1 hour, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Rodrigo Enriquez** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Noelia Sforza** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Dr. Marcela Rivera** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- An audience is requested to present information for the treatment of cardio-renal-metabolic diseases with iSGLT2 in Primary Health Care. Additionally, to be able to transmit results of projects to strengthen and update knowledge in health professionals in the APS network and the possibility of replicating these strategies.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/628861/718152).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hour, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1606696**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Fernando Reyes** on **June 18, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **June 18, 2024 at 03:00 PM**, a significant meeting was led by **Fernando Reyes**,  
serving as **Chief of Staff of the Undersecretary of Public Health**.  
ğŸ‘¤ **Meeting Leader**  
**Fernando Reyes** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: They will be received by the Office of the Undersecretary of Public Health. Mac-Iver 541, 3rd floor Phone: 225740407  
- **Format**: In person  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jose Allemant** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Vaccination DosesAttending from Abbott: Jose Allemant, Nicolas Pizarro, Roberto Sutelman and Axel Darroy.From Minsal, Chief of Staff of the Undersecretariat of Public Health, Dr. Fernando Reyes R and advisor Felipe Vera Ch.Topic: Vaccination Doses.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/564486/716988).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1607067**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **October 02, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **October 02, 2024 at 03:00 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://us02web.zoom.us/j/87629456128?pwd=33JljYVUPndaRytL0gsExAtALApyeU.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Monica Velasquez** â€“ Interest Manager, representing Fractal EDM
- **Magda Gutierrez Ardila** â€“ Interest Manager, representing Pfizer Chile S.A.
- **Maria Pons** â€“ Interest Manager, representing nan
- **Ruben Rojas** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Adolfo Araya** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the budgetary impact study and cost per respondent of Upadacitinib and Risankizumab in Psoriatic Arthritis in the context of Law 20,850. It is requested that the health technology assessment unit ETESA and Andrea Guerrero, technical secretary GES-SSP and Head of the Law unit Ricarte Soto, be present at the presentation. * Topics discussed: - Pharmacoeconomics studies of medications for Psoriatic Arthritis are presented. * Does not attend the hearing: Magda GutiÃ©rrez Rut 24772986-0, Abbvie Ltda. * The following people join the hearing. - Adolfo Araya, Rut 17,502,406-9, Abbvie Ltda. - Katherine Cerda Figueroa, ETESA-MINSAL - Catherine De La Puente Agurto, ETESA-MINSAL - Fabiola Rosso Chamorro, GES-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/743930).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1607560**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Roberto Araneda** on **October 17, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **October 17, 2024 at 11:00 AM**, a significant meeting was led by **Roberto Araneda**,  
serving as **Head of the Emergency Network Department-SRA.**.  
ğŸ‘¤ **Meeting Leader**  
**Roberto Araneda** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Vicente Moya** â€“ Lobbyist, representing Mediplex
- **Alejandro Meza Munoz** â€“ Interest Manager, representing Mediplex
- **Thomas Santibanez** â€“ Interest Manager, representing nan
- **Carolina Boxes** â€“ Interest Manager, representing Mediplex
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Dear Mr. Roberto Araneda, hoping that you are well, on this occasion we would like to present the benefits of using Aerogen (vibrating mesh nebulizer) and Airvo3 (high flow therapy) in the context of emergencies. We have seen good reception and excellent results in public institutions throughout Chile, so we believe it is feasible to discuss the scope of these therapies.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/667125/747062).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1608068**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Roberto Araneda** on **October 03, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **October 03, 2024 at 10:00 AM**, a significant meeting was led by **Roberto Araneda**,  
serving as **Head of the Emergency Network Department-SRA.**.  
ğŸ‘¤ **Meeting Leader**  
**Roberto Araneda** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: zoom  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Rodrigo Campos** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Light Maria Alvarez** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the Angels Initiative and continuing education courses for health professionals in stroke, free and certified by AHA-WSO and ESO.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/667125/747063).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1609460**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **July 11, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **July 11, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email lorenacamila.vega@pfizer.com  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Macarena Lagos** â€“ Interest Manager, representing nan
- **Lorena Vega** â€“ Interest Manager, representing nan
- **Denisse L Lara** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the Pegvisomant product for the treatment of acromegaly in Chile  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/723095).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1609546**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **October 09, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **October 09, 2024 at 03:40 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, contact phone number: 225740458, with the following connection link: https://us02web.zoom.us/j/89412482851?pwd=9vmBDcO1tcFxtdNgu71e1zO0f6lJ87.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Monica Velasquez** â€“ Interest Manager, representing Fractal EDM
- **Magda Gutierrez Ardila** â€“ Interest Manager, representing Pfizer Chile S.A.
- **Maria Pons** â€“ Interest Manager, representing nan
- **Ruben Rojas** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Sebastian Flores** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the cost-effectiveness and budgetary impact study of Upadacitinib in Ulcerative Colitis in the context of Law 20,850. It is requested that the health technology assessment unit (ETESA) and Andrea Guerrero, technical secretary of GES-SSP and Head of the Law unit, Ricarte Soto, be present at the presentation. *Topics covered: - Presents IP and cost-effectiveness study for a drug for ulcerative colitis. *Joining the audience: - Paula Rozenblum, Rut 24,569,494-9, ABBVIE - Andrea Guerrero, GES-MINSAL - Catherine De la Puente, ETESA-MINSAL *Not attending the hearing: - RubÃ©n Rojas, Rut 12241829-4, Fractal EDM  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/745293).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1611671**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **August 09, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers., preparation, issuance, modification, denial or rejection of administrative acts, bills and laws and also of the decisions taken by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 09, 2024 at 12:00 PM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers., preparation, issuance, modification, denial or rejection of administrative acts, bills and laws and also of the decisions taken by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Need help? Join the meeting now Meeting ID: 237 978 768 71 Passcode: EYNha4  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers., Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws and also of the decisions taken by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Luselia Tavares** â€“ Interest Manager, representing Johnson & Johnson
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Maria Guzman** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Guests: - Tamara Doberti- Emilia Reyes- Felipe Vera- Fernando GonzÃ¡lez- MarÃ­a JosÃ© GuzmÃ¡n -Mabeling Lam- MarÃ­a JosÃ© Espinoza - Pamela LlantÃ©n - Patricia del Carmen Gamboa- Ramiro Cofre- Tavares Lucelia- Clsa_ Collab_EnsenadaNovartis presents the SMA screening strategy that they carry out in Brazil, the testing flow. We ask you to share the presentation with us. Novartis offers the necessary training to install the neonatal SMA screening and we could make an agreement so that Novartis pays for the genetic tests. Novartis also offers to collaborate with the network of experts in Brazil and Canada to implement the screening. MINSAL reports that we have made progress in designing a strategy, but we are awaiting the budget discussion. The consultation is made on how Novartis could support with the gap in genetic confirmation and for the gap of having the Zolgensma treatment at a lower price. Novartis states: Regarding access to genetic testing, Novartis could pay for access to the tests. Regarding the price of Zolgensma, it is necessary to review it internally at Novartis because it is being reviewed as a region. It is agreed to hold a lobby meeting again when the budget law is advanced.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/733887).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers., preparation, issuance, modification, denial or rejection of administrative acts, bills and laws and also of the decisions taken by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1612711**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tamara Doberti** on **July 26, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **July 26, 2024 at 12:00 AM**, a significant meeting was led by **Tamara Doberti**,  
serving as **Head of Life Cycle Department**.  
ğŸ‘¤ **Meeting Leader**  
**Tamara Doberti** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Microsoft Teams Need help? Join the meeting now Meeting ID: 291 177 425 382 Passcode: 2fNAn4  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Luis Bonell** â€“ Interest Manager, representing Citizen Line
- **Patricio Jaureguiberry** â€“ Interest Manager, representing Science SPA
- **Eliana Ribeiro** â€“ Interest Manager, representing nan
- **Augusto Penayo** â€“ Interest Manager, representing nan
- **Monica Mora** â€“ Interest Manager, representing nan
- **Valentina Marin Vargas** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Members: - Augusto Penayo- Patricio Jaureguiberry- Valentina Marin Vargas- Tamara Doberti- Carolina de Pablo- Catherine de la Puente- Cristian Matamala- Cristina MarÃ­n- Emilia Reyes- Fabiola Rosso- MarÃ­a Francisca Briones- Pamela LlantÃ©n- Salvador Ãlvarez- Victoria HurtadoThe objective is to review the laboratory's proposal in order to acquire the Trikafta treatment for cystic fibrosis. The Guarantee Coordination Department requests that you send a quote format which will be requested by email. It is also reported that it is being studied for incorporation into GES. It is mentioned that the 15% decrease in the list price is still a high value. The laboratory mentions that they are available to discuss the possibility of an agreement on a financial basis, and that they have experience with agreements based on reimbursements. They offer a face-to-face meeting in September. We promise to gather the background information on the lawsuit, legal proceedings, and other information for this meeting. A meeting will be scheduled for the first half of October.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/573349/733173).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1613367**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **September 09, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 09, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Torrealba Diaz** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Renan Fuentealba** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- A second meeting is requested for the GES 2025 Evaluation, specifically in relation to iSLGT-2, in order to clarify doubts regarding the quotation process, which has a delivery deadline of July 5. Please schedule a meeting urgently.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/738268).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1615017**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Carmen Maria Aravena Cerda** on **July 04, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **July 04, 2024 at 09:30 AM**, a significant meeting was led by **Carmen Maria Aravena Cerda**,  
serving as **Head of Primary Care Division-SRA**.  
ğŸ‘¤ **Meeting Leader**  
**Carmen Maria Aravena Cerda** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The audience will be received via video conference, connect to the link Enter Zoom Meeting https://us02web.zoom.us/j/85323730171?pwd=Liwghy6Z0UE7oQWnPXhNVaXDcUrMpu.1 Meeting ID: 853 2373 0171 Access code: 824739 any questions call 22574003  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Luis Gardel** â€“ Interest Manager, representing nan
- **Jose Allemant** â€“ Interest Manager, representing nan
- **Alvaro Molina** â€“ Interest Manager, representing nan
- **Javiera MuÃ±oz** â€“ Interest Manager, representing nan
- **Carmen Maria Aravena Cerda** â€“ nan, representing nan
- **Camilo Becerra** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Covid/flu test - Rapid diagnostic technologies for respiratory viruses that can be used at the point of care are presented.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/628861/721949).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1615812**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **July 18, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 39 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **July 18, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The Teams link will be sent by email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 39 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Francisco Pinto** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Alvaro Sepulveda** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Ariel Blua** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Lobbying is requested to find out about the possibility of LEP review. A prior meeting is held with Carolina Neira DIPRECE who suggests requesting this hearing with Ms. Andrea Guerrero and the ETESA department.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/724413).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 39 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1617740**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Juan Collao** on **July 26, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers. celebration, modification or termination of any kind of contracts made by taxpayers that are necessary for their operation.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **July 26, 2024 at 11:00 AM**, a significant meeting was led by **Juan Collao**,  
serving as **Head of the Department of Pharmaceutical Policies and Regulations, Health Providers and Complementary Medicines.**.  
ğŸ‘¤ **Meeting Leader**  
**Juan Collao** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers. celebration, modification or termination of any kind of contracts made by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be assisted by Mr. Collao, the connection link will be sent shortly.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers. Celebration, modification or termination of any kind of contracts made by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Daniel Munoz** â€“ Interest Manager, representing Recemed SPA
- **Pablo JaÃ±a** â€“ Interest Manager, representing Recemed SPA
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- We requested this meeting to learn about the progress of the Electronic Medical Prescription project, along with the Technical Standard for private platforms for issuing Electronic Prescriptions.TOPICS ADDRESSED AT THE MEETING:The meeting begins with the appropriate introductions.Later, the progress of the electronic prescription project is discussed, and it is also noted that the trial run will be launched soon.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/622861/732660).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers. celebration, modification or termination of any kind of contracts made by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1618692**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **July 26, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **July 26, 2024 at 09:00 AM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The following room is created: Link https://us02web.zoom.us/j/85408360927 Password 983340  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Catalina Agosin** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Update on the fate of the Institutionâ€¢ Catalina AgosÃ­n is introduced: president of the Corporation.â€¢ The Corporation is dedicated to education, prevention, early diagnosis, research and treatment of cancer in our country.â€¢ The meeting was requested in the context of the subsidized sale of opioids in the 8 oncology medicine cabinets located in Santiago (2), Antofagasta, ConcepciÃ³n, Temuco and Valdivia. Approximately 160,000 injectables are dispensed per year to patients affiliated with ISAPRES. These medicine cabinets have losses of around $80MM annually due to a decrease in donations. Since the 90s they have not received state contributions in this line. They cannot close the year. Request donations to ensure operational continuity.â€¢ Also, they have been in conversation with ANAMED to add 3 additional items to the check prescription: name of the person who picks up, Run and address to facilitate delivery of information to PDI in case of fraud.â€¢ They deliver medications in perpetuity to 180 GIST patients.â€¢ Given the nature of the request, it is suggested that you request an extended meeting with the ministerial cabinet chief.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/726697).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1622243**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **September 23, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 23, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Meeting room: https://us02web.zoom.us/j/83410405853 Password 959537  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Oviedo** â€“ Lobbyist, representing Merck SA
- **Diego Rojas** â€“ Interest Manager, representing nan
- **Carolina Zarate** â€“ nan, representing nan
- **Pablo VASQUEZ** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Meeting starts at 3:00 pm. Attendees introduce themselves. A technical proposal is presented for the use of Cetuximab (Erbitux), indicating its mechanisms of action in patients with non-surgical locally advanced head and neck cancer, in conjunction with radiotherapy, unfit for cisplatin and in patients with metastatic recurrent head and neck cancer, indicating survival results, adverse effects and impact on quality of life. Merck Laboratory refers to the possible inclusion of this drug in DAC and MINSAL indicates that the new DAC decree has just been published, so there is no new date on which it is planned to update it. What can be done at this time is to receive information on new technologies and studies that are emerging. Merck Laboratory indicates that they have invitations to scientific events and is asking how they can be delivered to the ANACAN Department. Carolina and Pablo indicate that it is not permitted to receive invitations from the pharmaceutical industry since this constitutes a lack of integrity and a conflict of interest. MINSAL requests a presentation and the studies to observe the results in the different subgroups of head and neck cancer; and to copy Rodrigo LÃ³pez, Lobby representative of the ANACAN Department, in this submission. Presentation ends at 3:30 p.m.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/740389).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1622295**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **October 10, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **October 10, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The following session is created for the audience: Link https://us02web.zoom.us/j/82332640372 Password 250016  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Oviedo** â€“ Lobbyist, representing Merck SA
- **Diego Rojas** â€“ Interest Manager, representing nan
- **Francisca Plaza** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Diego presented the results of the JAVELIN Bladder 100 study, which focused on the use of avelumab for the treatment of locally advanced or metastatic urothelial carcinoma in patients who have remained progression-free after receiving platinum-based chemotherapy. Francisca commented that the Clinical Practice Guideline for Bladder Cancer in people 15 years of age or older was recently published, and indicated that said guideline includes relevant recommendations for this group of patients. MERCK representatives will send the presentation in PowerPoint format to Francisca's email.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/745519).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1624514**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **September 05, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 05, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: teams will be sent by mail  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Francisco Pinto** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Alvaro Sepulveda** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Rocio Masferrer** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Proposal for GES implementation 2025-2028.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/738066).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1628339**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **August 08, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 36 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 08, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 36 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Sonia Torrealba** â€“ Interest Manager, representing Novartis Chile S.A.
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- The objective of the meeting is:1. Status of the new DAC process for the year 2024 (methodology, threshold; procedures; information system; others)2. Presentation of asciminib for the treatment of chronic myeloid leukemia and use in Health Care Networks3. Execution of the DAC budget  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/730759).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 36 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1629558**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Veronica Bustos** on **August 20, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 15 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 20, 2024 at 03:00 PM**, a significant meeting was led by **Veronica Bustos**,  
serving as **Head of the Human Resources Management and Development Division (DIGEDEP)**.  
ğŸ‘¤ **Meeting Leader**  
**Veronica Bustos** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The Head of the Division and Development of People, VerÃ³nica Bustos, will receive it. In addition, the Head of Budget Alfredo RomÃ¡n and the Head of DIGERA, Dr. Andrea SolÃ­s, will be there. Contact Violeta Martinic at 225740345. TEAMS is attached to connect. Join the meeting at  
- **Format**: Videoconference  
- **Duration**: 0 hours, 15 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Cynthia Martinic** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- REQUESTS A MEETING WITH THE UNDERSECRETARY OR, IN HIS FAULT, THE CHIEF OF CABINET OR CABINET LAWYER, FOR THE PURPOSES OF ANNOUNCING THE REPORT THAT ANALYZES PERSONNEL PURCHASES MADE BY THE REGIONAL HOSPITAL OF TALCA.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/650558/733064).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 15 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1630848**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Elizabeth Lopez** on **August 13, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **August 13, 2024 at 10:00 AM**, a significant meeting was led by **Elizabeth Lopez**,  
serving as **Head of the Immunization Department**.  
ğŸ‘¤ **Meeting Leader**  
**Elizabeth Lopez** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Zoom link will be sent to marjorie.g.vasquez@gsk.com  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Marjorie Vasquez** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Tamara Rosales** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- The laboratory presents evidence of the protection of the Bexsero vaccine against invasive meningococcal disease caused by meningococcus B, and its immunogenicity.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/678098/744550).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1632093**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **July 31, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **July 31, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The following session is created for the audience: Link https://us02web.zoom.us/j/89834950122 Password 133446  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Macarena Gutierrez** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Ruben Rojas** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Felipe Moraes** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- The Department's professional, Gina Merino, was expected to speak until 3:13 p.m. Unfortunately, no connection was made by GSK.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/729024).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1637119**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Yasmina Viera** on **August 19, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 19, 2024 at 03:30 PM**, a significant meeting was led by **Yasmina Viera**,  
serving as **Head of Legal Division**.  
ğŸ‘¤ **Meeting Leader**  
**Yasmina Viera** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The connection link will be sent by email  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Claudia Farjat** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- AME  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/458394/754676).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1638626**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Albagli** on **September 12, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 12, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Albagli**,  
serving as **Undersecretary of Public Health**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Albagli** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: They will be contacted by the Office of the Undersecretary of Public Health. Telephone: 225740407  
- **Format**: In person  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **May Chomali Garib** â€“ Interest Manager, representing Census
- **Felix Joaquin Liberona Duran** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the work carried out by CENS, both nationally and internationally. They were received by advisors from the Office of the Undersecretary of Public Health, Sara Correa, Fabiola Pinochet and from Diplas. Topics were discussed on better connections to improve health care for people.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/557884/743808).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1640878**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **August 28, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **August 28, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The following room is created: Link https://us02web.zoom.us/j/84484774508 Password 583993  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Sonia Torrealba** â€“ Interest Manager, representing Novartis Chile S.A.
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Francisca Plaza, a professional from ANACAN, waited until 3:15 p.m., without any representatives from Novartis showing up.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/735956).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1642582**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Carmen Maria Aravena Cerda** on **September 26, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **September 26, 2024 at 10:00 AM**, a significant meeting was led by **Carmen Maria Aravena Cerda**,  
serving as **Head of Primary Care Division-SRA**.  
ğŸ‘¤ **Meeting Leader**  
**Carmen Maria Aravena Cerda** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Meeting will be hosted by Dr. Carmen Aravena and Daniela Cortes via zoom https://us02web.zoom.us/rec/share/bQ1C_OhucfjXHEyWzYgsi6SOo_dH53Lg9xHLNNP-ouzexbc82ieQ_MV1htMNfINm.NoCwuYe89u6RP8qD Access code: zcQ5fBG= if you have any questions ll  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Roberto Lopez** â€“ Interest Manager, representing Novo Nordisk FarmacÃ©utica Ltda.
- **Flavio Del Pino** â€“ Interest Manager, representing Novo Nordisk FarmacÃ©utica Ltda.
- **Cristina Metzdorff** â€“ Interest Manager, representing nan
- **Daniela Cortes** â€“ nan, representing nan
- **Roberto Lopez** â€“ Interest Manager, representing Novo Nordisk FarmacÃ©utica Ltda.
- **Flavio Del Pino** â€“ Interest Manager, representing Novo Nordisk FarmacÃ©utica Ltda.
- **Cristina Metzdorff** â€“ Interest Manager, representing nan
- **Daniela Cortes** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Topics addressed: They reported the non-continuation of product production lines, specifically the manufacture of NPH and Cristalina insulin cartridges, which are being used in pilots in some Health Services, so at the local level they must evaluate the change in treatment or the continuity with the ampoule vial. This information will be forwarded to the SS.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/628861/743355).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1645387**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **October 21, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **October 21, 2024 at 11:00 AM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams link will be sent by email  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Patricio Jaureguiberry** â€“ Interest Manager, representing Science SPA
- **Augusto Penayo** â€“ Interest Manager, representing nan
- **Valentina Marin Vargas** â€“ Interest Manager, representing nan
- **Salvador Alvarez** â€“ Interest Manager, representing nan
- **Cristina Martin Rinconada** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- They will ask for a new lobby later.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/747657).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1646450**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Raquel Child Goldenberg** on **August 21, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **August 21, 2024 at 03:00 AM**, a significant meeting was led by **Raquel Child Goldenberg**,  
serving as **Head of the Office of Cooperation and International Affairs (OCAI).**.  
ğŸ‘¤ **Meeting Leader**  
**Raquel Child Goldenberg** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Nuns 689  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Alvaro Melys** â€“ Interest Manager, representing nan
- **Mariella Francesca Parodi Soza** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Isidore Prudent** â€“ Interest Manager, representing nan
- **Favio Mesquita** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- We request a meeting to present evidence on our long-acting therapy as a response to stigma, discrimination and adherence in PLHIV.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/628244/733109).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1647321**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **November 06, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 06, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: The following room is created to carry out the hearing: Link https://us02web.zoom.us/j/83986019608 Password 310116  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Fernanda Rivera** â€“ Interest Manager, representing Roche Chile Limited
- **Paz Mocarquer Semler** â€“ Interest Manager, representing nan
- **Gina Merino** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Different alternatives for performing self-sampling tests for molecular determination of Human Papillomavirus (HPV) are presented, and methods of use, characteristics of the instruments, storage and transport are specified. ROCHE mainly works with FLOQSwabs and Evalyn Brush products. The economic proposal will depend on the volume and the selected alternative. Agreements: sending a presentation to be shared with DIVAP and DIGERA representatives.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/754975).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1648137**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **November 06, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 06, 2024 at 03:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://minsal-cl-epi.zoom.us/j/87688126823?pwd=paBhkSyaShwbyzsAIyptNYFMrQgUgz.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Eduardo Sebastian Olivares Saavedra** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Cecilia Panzone** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Pablo Munoz** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- meeting is requested to present data and background information regarding the treatment of hepatocarcinoma with Durvalumab/Tremelimumab and its eventual evaluation for incorporation into coverage mechanisms.*TOPICS DISCUSSED:-Presentation on the Himalayan study on hepatocarcinoma immunotherapy.*The following join the hearing:-Victoria Hurtado Meneses, ETESA-MINSAL-Ramiro CofrÃ© CofrÃ©, GES-MINSAL*Does not attend the hearing:-Eduardo Olivares Saavedra, Rut 16288594-4, Interest Manager, AstraZeneca Chile  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/753742).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1648444**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Patricia Contreras Cerda** on **September 11, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 37 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 11, 2024 at 12:00 PM**, a significant meeting was led by **Patricia Contreras Cerda**,  
serving as **Head of Department of Communicable Diseases - DIPRECE SSP**.  
ğŸ‘¤ **Meeting Leader**  
**Patricia Contreras Cerda** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams  
- **Format**: Videoconference  
- **Duration**: 0 hours, 37 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Macarena Vergara** â€“ Interest Manager, representing Rochem Biocare Chile
- **Lucia Acosta Ramirez** â€“ Interest Manager, representing Rochem Biocare Chile
- **MONICA CONDE** â€“ Interest Manager, representing CEPHEID
- **Luis Vela** â€“ Interest Manager, representing CEPHEID
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Request for a meeting with the technical managers of the National Tuberculosis Program to review the current situation of the GeneXpert network's own equipment in the country with representatives of the manufacturer. Lobby participated in this hearing along with Ms. Patricia Contreras, Dr. Mary Hatton - Head (S) Tuberculosis Control and Elimination Program and Natalia Ruiz - Nurse Coordinator of the Tuberculosis Control and Elimination Program, both professionals from the Department of Communicable Diseases.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/174504/739107).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 37 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1648495**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Elizabeth Lopez** on **August 16, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **August 16, 2024 at 10:00 AM**, a significant meeting was led by **Elizabeth Lopez**,  
serving as **Head of the Immunization Department**.  
ğŸ‘¤ **Meeting Leader**  
**Elizabeth Lopez** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Zoom video conference  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Monica Daniela Assef Rock** â€“ Interest Manager, representing Chamber of Direct Sales Medicines, CAMEVED
- **Paula Arias** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- The Takeda Chile Laboratory was presented with the aim of learning about the Ministry's needs in the provision of immunization technologies.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/678098/744518).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1651590**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **September 10, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 36 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 10, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 36 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Efrain Flores Moreno** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Within the framework of Resolution No. 1099 dated August 14, 2024, review of the DAC process for the indication for breast cancer.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/738717).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 36 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1652454**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Christian Cofre** on **November 13, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **November 13, 2024 at 10:00 AM**, a significant meeting was led by **Christian Cofre**,  
serving as **Head of the Department of Nutrition and Food-DIPOL.**.  
ğŸ‘¤ **Meeting Leader**  
**Christian Cofre** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be contacted by the Food and Nutrition department via Telematics: Telephone: 225740474  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jose Santander** â€“ Interest Manager, representing nan
- **Juan ARTHUR** â€“ nan, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Topics to be discussed:Represent the public health problems that exist in Chile as a result of the Marketing of Food and Sports Supplements, which in their great majority do not have the properties that they claim to have.Represent the composition problems of these products.Present laboratory analyses carried out by our representative, which expose that products sold in the notional market do not match their labeling.Represent the lack of diligence that the ISP and the respective SEREMI have had, before complaints made by our representative.Topics discussed:Clients JyJ has made complaints about the composition of food supplement products and the quality of ingredients.They want to know about the path to take regarding the known lack of response from the Seremi de Salud/Undersecretariat of Public Health or ISP.The formal routes are indicated to send requests and letters to the Minsal Parts Office  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/684820/755575).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1654656**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Elizabeth Lopez** on **August 30, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **August 30, 2024 at 10:30 AM**, a significant meeting was led by **Elizabeth Lopez**,  
serving as **Head of the Immunization Department**.  
ğŸ‘¤ **Meeting Leader**  
**Elizabeth Lopez** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Videoconference via Zoom platform  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Monica Daniela Assef Rock** â€“ Interest Manager, representing Chamber of Direct Sales Medicines, CAMEVED
- **Paula Arias** â€“ Interest Manager, representing nan
- **Andrea Kauak** â€“ Interest Manager, representing nan
- **Cecilia Magneres** â€“ Interest Manager, representing nan
- **Fabio Carvalho** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Scientific presentation of Takeda Laboratory's TAK-003 vaccine against dengue, by Dr. Cecilia Magneres.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/678098/744513).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1656173**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **November 20, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 20, 2024 at 03:30 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
- **Maria Guzman** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Ricarte Soto Law. During the public address of the President of the Republic on June 1, 2024, as well as in the public address of the Ministry of Health, the entry into force of the decree that incorporates three new drugs to the Ricarte Soto Law was announced. According to the reports published by the Ministry of Health, this decree generates significant savings for the health system. We would appreciate an audience to learn about the progress in the process of processing this decree as well as the estimated date on which it will come into force.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/755805).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1658058**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Letelier** on **September 13, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **September 13, 2024 at 08:00 AM**, a significant meeting was led by **Maria Letelier**,  
serving as **Head of Digital Health Department**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Letelier** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join Zoom Meeting https://us02web.zoom.us/j/86293914607?pwd=knuAG4iPRLEDxJ5lddWHdawWcf8j3Y.1 Meeting ID: 862 9391 4607 Passcode: 613544  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Gonzalez** â€“ Lobbyist, representing Roche Chile Limited
- **Christhian Chamba** â€“ Interest Manager, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Nevity is presented, which is an integration bus for interoperability. It is reported that the ICT Department is in charge of the interoperability issue at MINSAL, and that they are the ones who can give you more information about the architecture and the next steps. The possibility of carrying out a pilot or searching for an opportunity to support pathological anatomy with the digitalization of these services is presented. It is indicated that INCANCER is an establishment that is always willing to move forward in this and that perhaps they should contact them through the lobby law to find out what they are doing and how they could help them.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/305882/739714).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1660731**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Sung Kim** on **November 27, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 27, 2024 at 03:00 PM**, a significant meeting was led by **Sung Kim**,  
serving as **Head of the Department of Comprehensive Management of Cancer and Other Tumors-DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Sung Kim** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Link https://us02web.zoom.us/j/81681093953 Password 938783  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Sonia Torrealba** â€“ Interest Manager, representing Novartis Chile S.A.
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- In the context of the breast cancer health problem, presentation of the clinical differences between CDK 4/6 for the treatment of breast cancer.-â€¢ Melanie Paccot 15.671.523-9 and Sung Kim attend.â€¢ Discussion is held on the OECD drug coverage document, the concern about the resolution that rectifies the DAC resolution and the agreement with the second FONASA provider that includes financing for ribociclib.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/651929/757520).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1661668**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **September 30, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 30, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams was sent by mail  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Carlos Hernandez** â€“ Interest Manager, representing nan
- **Rachel Marina Hernandez** â€“ Interest Manager, representing nan
- **Lorena Vega** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- A meeting is requested for the presentation of Lorlatinib, a drug included in resolution 1099 on high-cost oncology drugs, with the aim of seeing the implementation of the purchasing process.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/742229).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1663693**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Letelier** on **October 04, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **October 04, 2024 at 08:00 AM**, a significant meeting was led by **Maria Letelier**,  
serving as **Head of Digital Health Department**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Letelier** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join Zoom Meeting https://us02web.zoom.us/j/87056272608?pwd=0bEgy6bsnmq4uGClECcYoPhS1AVWnb.1 Meeting ID: 870 5627 2608 Passcode: 208001  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Sonia Torrealba** â€“ Interest Manager, representing Novartis Chile S.A.
- **Maria Guzman** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of the Health Innovation Hub project and analysis of possible areas of collaboration. Presentation of the Loa Innovation Hub strategy that seeks to have positive impacts on patient health through areas of innovation, education, research and intelligence. The strategy hopes to have an advisory committee that indicates which are the necessary priorities for the country. This committee would be made up of different entities such as ministries, universities and other relevant entities. It was indicated that an initiative of this type would be interesting and that it should be evaluated with the different instances how it could be implemented and what the participation of MINSAL would be.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/305882/746177).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1666401**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **November 27, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 27, 2024 at 03:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone 225740458, with the following connection link: https://minsal-cl-epi.zoom.us/j/87551781049?pwd=d4YOvGyyoUI8vLgETsiWRp0IfX69Gu.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Alejandra Cisneros** â€“ Interest Manager, representing Bristol-Myers Squibb Chile
- **Maria De Fruits** â€“ Interest Manager, representing Bristol Myers Squibb Company
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- I request an audience for the presentation of a commercial proposal for Nivolumab_various indications.*TOPICS DISCUSSED: Commercial proposal for Nivolumab that was sent in September 2024 for ARC.*The audience is joined by: Nancy Osses, Rut 12.849,.967, BMS Andrea Guerrero, GES-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/757801).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1667648**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Espinoza** on **October 09, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **October 09, 2024 at 09:00 AM**, a significant meeting was led by **Maria Espinoza**,  
serving as **Head of the GES Complex Networks and Programmatic Lines Department.**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Espinoza** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Link https://us02web.zoom.us/j/83480296758 Password 147297 is done effectively  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Omar Landaeta** â€“ Interest Manager, representing nan
- **Patricia Saldivia** â€“ Interest Manager, representing nan
- **Maria Guzman** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- New presentation of 300 mg subcutaneous (SC) secukinumab for psoriatic arthritis, a molecule guaranteed by the Ricarte Soto Law. CENABAST and the DIPLAS Guarantee Coordination Department have informed us that we must request a meeting with the DIGERA GES and Complex Networks Department. This dosage is supported by the Ricarte Soto Law protocol and has no budgetary impact.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/717439/746525).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1668286**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **November 14, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 14, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent by mail  
- **Format**: Videoconference  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Beethoven Colonel Nunez** â€“ Interest Manager, representing Sanofi
- **Maria Gonzalez** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up on Dupilumab severe asthma (GES) quote, they agreed to send economic model documentation.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/754492).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1668677**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **September 25, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 20 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 25, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams  
- **Format**: Videoconference  
- **Duration**: 0 hours, 20 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Jose Luis Sarabia** â€“ Lobbyist, representing Abbott Laboratories of Chile Limited
- **Veronica Guzman** â€“ Lobbyist, representing Abbott Laboratories of Chile Limited
- **Maria Carballeira** â€“ Lobbyist, representing Abbott Laboratories of Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Evaluation and economic, technical and administrative information about glucose sensor for GES  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/740916).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 20 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1669179**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Maria Letelier** on **October 11, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **October 11, 2024 at 08:00 AM**, a significant meeting was led by **Maria Letelier**,  
serving as **Head of Digital Health Department**.  
ğŸ‘¤ **Meeting Leader**  
**Maria Letelier** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Join Zoom Meeting https://us02web.zoom.us/j/81535186886?pwd=Lmw4KwtVttUyRYWi6A12ub2X1HV1GP.1 Meeting ID: 815 3518 6886 Passcode: 835610  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ingrid Gaete** â€“ Interest Manager, representing TECNIKA SA
- **Jose Antonio Alvarado** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of MEDICIP HEALTH, a company with more than 25 years of experience and a provider of cutting-edge technology systems, and presence in at least 10 countries in Latin America and Europe. They present the devices that the company has in technology mainly for managing patient admission, patient falls or monitoring in the establishment. It is indicated that the Investment Division is the one who sees the establishments under construction and defines the requirements. It is recommended that you request a meeting with them.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/305882/746171).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1669844**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **October 17, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 45 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **October 17, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 45 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Natalia Celedon** â€“ Interest Manager, representing nan
- **Renzo Wong** â€“ Interest Manager, representing nan
- **Paula Nahuelhual** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- 1. Follow-up of the proposed Shared Risk Agreement (SAR) for high-risk early-stage triple-negative breast cancer and update of effectiveness data.2. Melanoma DAC indication not available in MAI and MLE3. Absence of pembrolizumab in DAC platform for lung 2nd line  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/747103).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 45 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1670486**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **September 25, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 22 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **September 25, 2024 at 04:30 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 22 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Lorena Gonzalez** â€“ Lobbyist, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Topics to be discussed and requested by this unit, quote for the supply of glucose sensors for the GES  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/740939).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 22 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1672280**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **November 04, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 33 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 04, 2024 at 03:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent by mail.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 33 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ximena Paredes** â€“ Interest Manager, representing Roche Chile Limited
- **Lorena Pilar Bustos Xaus** â€“ Interest Manager, representing Roche Chile Limited
- **Denisse CaÃ±ete** â€“ Interest Manager, representing Roche Chile Limited
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of value proposals for oncology portfolio and doubts in the implementation of the new DAC resolution  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/751509).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 33 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1676257**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **November 28, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 28, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Francisco Pinto** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Rodrigo Enriquez** â€“ Interest Manager, representing Astrazeneca Laboratory
- **Alvaro Sepulveda** â€“ Interest Manager, representing Astrazeneca Laboratory
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up to the presentation of information made through a lobby hearing, in July 2024, regarding innovative triple therapy for the treatment of COPD.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/757996).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1681060**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Elizabeth Lopez** on **November 05, 2024**, focused on **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **November 05, 2024 at 11:00 AM**, a significant meeting was led by **Elizabeth Lopez**,  
serving as **Head of the Immunization Department**.  
ğŸ‘¤ **Meeting Leader**  
**Elizabeth Lopez** plays a critical role in addressing the **preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Videoconference, has been entrusted to Dr. Elizabeth LÃ³pez - Head of the Immunization Department, she will send a link in due time, any questions at 225688128  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Marjorie Vasquez** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
- **Jessica RUT Jassir Felfle** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- GlaxoSmithKline presents new clinical data on the Arexvy vaccine, which protects against respiratory syncytial virus (RSV) in the population aged 50 and older. In Chile, the ISP has approval for vaccines from 60 years of age, and the laboratory will soon present this new data to expand the age group from 50 years of age.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/678098/757724).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding preparation, issuance, modification, denial or rejection of administrative acts, bills and laws, as well as decisions made by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1683429**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Adrian Pena** on **October 25, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **1 hours, 0 minutes**.  
ğŸ“… **Date and Time**  
On the morning of **October 25, 2024 at 09:00 AM**, a significant meeting was led by **Adrian Pena**,  
serving as **Head of Department of Studies - Ms.**.  
ğŸ‘¤ **Meeting Leader**  
**Adrian Pena** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Monjitas 689 of. 34 floor 3 Mr. Carlos Manzi Astudillo, Head of Investment Division  
- **Format**: In person  
- **Duration**: 1 hours, 0 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Ingrid Gaete** â€“ Interest Manager, representing TECNIKA SA
- **Lucinda Perez Barahona** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Presentation of a Spanish company, a provider of cutting-edge technology systems. During the hearing, the company's offerings are presented and it is suggested that they again enter a lobby indicating that they develop comprehensive solutions associated with ICT in health establishments.  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/581982/757541).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **1 hours, 0 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1686951**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Tania Herrera** on **November 27, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 30 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 27, 2024 at 02:30 PM**, a significant meeting was led by **Tania Herrera**,  
serving as **Head of Health Planning Division**.  
ğŸ‘¤ **Meeting Leader**  
**Tania Herrera** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: You will be received by Dr. Tania Herrera MartÃ­nez, Head of the Health Planning Division, telephone: 225740458, with the following connection link: https://minsal-cl-epi.zoom.us/j/83593110268?pwd=VHqlYduU7Sopb8V8kfgekpGXIWYs4U.1  
- **Format**: Videoconference  
- **Duration**: 0 hours, 30 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Sonia Torrealba** â€“ Interest Manager, representing Novartis Chile S.A.
- **Melanie Paccot** â€“ Interest Manager, representing Novartis Chile S.A.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Follow-up to the DAC process, in relation to primary coverage in breast cancer.*Topics covered:Follow-up to the DAC resolution on breast cancer, specifically cyclines.-Modification of therapeutic lines-Purchase-Tender*The following people join the audience:Claudia Farjat, Rut 27.498.393-9, NorvatisConstanza Salas, ETESA-MINSALEduardo QuiÃ±elÃ©n, ETESA-MINSALVictoria Hurtado, ETESA-MINSALAndrea Guerrero, GES-MINSAL  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/525076/757570).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 30 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1687663**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Edith Carmen Ortiz NuÃ±ez** on **November 11, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 45 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 11, 2024 at 03:00 PM**, a significant meeting was led by **Edith Carmen Ortiz NuÃ±ez**,  
serving as **Head (S) Department of the National Program for the Prevention and Control of HIV/AIDS and STIs DIPRECE**.  
ğŸ‘¤ **Meeting Leader**  
**Edith Carmen Ortiz NuÃ±ez** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: According to your request, Dr. Leonardo Chanqueo, Head of the Department of the National Program for the Prevention of HIV/AIDS and STIs, will contact you together with Mrs. Edith Ortiz. Contact 225740677 or 225740680  
- **Format**: In person  
- **Duration**: 0 hours, 45 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Alvaro Melys** â€“ Interest Manager, representing nan
- **Mariella Francesca Parodi Soza** â€“ Interest Manager, representing GlaxoSmithKline Chile FarmacÃ©utica Ltda
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Given the importance for the Ministry to continue to confront the HIV epidemic from the prevention, diagnosis, treatment and quality of life, we requested an audience with the Minister, Dr. Ximena Aguilera, to share the innovative approach that GSK-ViiV has for the pathology, mainly in the long-acting portfolio that includes treatment and PrEP, aligned with the WHO recommendation. Matters discussed in lobby:In relation to the meeting matters:They make a presentation in which they point out that according to some studies, user satisfaction with this type of treatment would increase and with it adherence. The indication for the use of this type of ARV is for switch, in people without resistance. They carried out a cost-effective analysis comparing with the ART schemes of the current decree (they used schemes from both the start and rescue baskets), which concludes that using injectable ARV (cabotegravir + rilpivirine) is less expensive. They also present an instrument that would allow calculating the human resources needed to implement this ARV of According to the number of people who would use it, estimating that 1 hour of professional work per week is required for 15 users who use this drug. In relation to the use of this ARV for PrEP, they point out that the process of obtaining the health resolution for this use is still in progress. Lobby participants: HIV Program Department Yasna AlarcÃ³n / MarÃ­a Teresa Silva According to the Glaxo laboratory, JosÃ© Pozo participated via email request  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/275447/756233).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 45 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1689304**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **November 18, 2024**, focused on **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** and lasted for **0 hours, 20 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 18, 2024 at 03:30 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to your email.  
- **Format**: Videoconference  
- **Duration**: 0 hours, 20 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **John Corona** â€“ Interest Manager, representing nan
- **Alberto Franguini** â€“ Interest Manager, representing nan
- **Claudio Covini** â€“ Interest Manager, representing nan
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- In the context of the recent publication of the 2024 protocol, we respectfully request to meet with Dr. Tania Herrera, head of DIPLAS, to make inquiries regarding Intravenous Natalizumab and the recent application of Subcutaneous Natalizumab. (Closed without anything to add)  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/754955).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 20 minutes** and concluded with actionable insights regarding celebration, modification or termination of any type of contracts entered into by taxpayers that are necessary for their operation..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================

ğŸ†” **Meeting Identifier**  
**AO001AW1695122**  
ğŸ“‹ **Meeting Summary**  
This meeting, led by **Andrea Guerrero** on **November 27, 2024**, focused on **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** and lasted for **0 hours, 27 minutes**.  
ğŸ“… **Date and Time**  
On the afternoon of **November 27, 2024 at 04:00 PM**, a significant meeting was led by **Andrea Guerrero**,  
serving as **Head of Technical Secretariat GES - SSP and Head of Ricarte Soto Unit.**.  
ğŸ‘¤ **Meeting Leader**  
**Andrea Guerrero** plays a critical role in addressing the **design, implementation and evaluation of policies, plans and programs carried out by taxpayers.** as part of their responsibilities within the government framework.  
ğŸ“ **Location and Format**  
- **Location**: Teams will be sent to the email  
- **Format**: Videoconference  
- **Duration**: 0 hours, 27 minutes  
ğŸ¯ **Focus and Objectives**  
The primary focus of the discussion revolved around the **Design, implementation and evaluation of policies, plans and programs carried out by taxpayers.**.  
ğŸ‘¥ **Participants and Representatives**  
Attendees actively contributed to the session, sharing insights and perspectives on the matter at hand.  
- **Claudia Torrealba Diaz** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
- **Renan Fuentealba** â€“ Interest Manager, representing BOEHRINGER INGELHEIM LTDA.
ğŸ“„ **Meeting Highlights and Notes**  
During the meeting, the following topics and points were discussed:  
- Empagliflozin-GES meeting is held - New request for hearing will be made  
ğŸ”— **Official Record Link**  
For further details, [access the full meeting record here](https://www.leylobby.gob.cl/instituciones/AO001/audiencias/2024/109889/757526).  
ğŸ“Š **Summary and Significance**  
The meeting lasted **0 hours, 27 minutes** and concluded with actionable insights regarding design, implementation and evaluation of policies, plans and programs carried out by taxpayers..  
The contributions of the attendees enriched the discussion, fostering transparency and comprehensive decision-making.  
This meeting highlights the **dedication and collaborative efforts** of public officials and stakeholders in shaping key policies and programs for the betterment of governance and public service.  
==============================================================================================================================
